<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Lipid Res</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Lipid Res</journal-id>
<journal-id journal-id-type="hwp">jlr</journal-id>
<journal-id journal-id-type="pmc">jlr</journal-id>
<journal-id journal-id-type="publisher-id">jlr</journal-id>
<journal-title-group>
<journal-title>Journal of Lipid Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0022-2275</issn>
<issn pub-type="epub">1539-7262</issn>
<publisher>
<publisher-name>The American Society for Biochemistry and Molecular Biology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32487545</article-id>
<article-id pub-id-type="pmc">7397749</article-id>
<article-id pub-id-type="publisher-id">r120000800</article-id>
<article-id pub-id-type="doi">10.1194/jlr.R120000800</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Roles of polyunsaturated fatty acids, from mediators to membranes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-2235-4197</contrib-id>
<name>
<surname>Harayama</surname>
<given-names>Takeshi</given-names>
</name>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff1">*</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-9097-1357</contrib-id>
<name>
<surname>Shimizu</surname>
<given-names>Takao</given-names>
</name>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">†</xref>
</contrib>
<aff id="aff1"><label>*</label>Department of Biochemistry and National Centre of Competence in Research in Chemical Biology, <institution>University of Geneva</institution>, CH-1211 Geneva, <country>Switzerland</country></aff>
<aff id="aff2"><label>†</label>Department of Lipid Signaling, <institution>National Center for Global Health and Medicine</institution>, Shinjuku-ku, Tokyo 162-8655, <country>Japan</country> and Department of Lipidomics, Graduate School of Medicine, <institution>University of Tokyo</institution>, Bunkyo-ku, Tokyo 113-0033, <country>Japan</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label>To whom correspondence should be addressed. e-mail: <email>harayama-t@umin.net</email> (T.H); <email>tshimizu@ri.ncgm.go.jp</email> (T.S.)</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>8</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>2</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>2</day>
<month>6</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>61</volume>
<issue>8</issue>
<fpage>1150</fpage>
<lpage>1160</lpage>
<history>
<date date-type="received">
<day>31</day>
<month>3</month>
<year>2020</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>5</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2020 Harayama and Shimizu. Published by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Harayama and Shimizu</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>
<italic><bold>Author’s Choice</bold>—Final version open access under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">Creative Commons CC-BY license</ext-link>.</italic>
</license-p>
</license>
</permissions>
<abstract>
<p>PUFAs, such as AA and DHA, are recognized as important biomolecules, but understanding their precise roles and modes of action remains challenging. PUFAs are precursors for a plethora of signaling lipids, for which knowledge about synthetic pathways and receptors has accumulated. However, due to their extreme diversity and the ambiguity concerning the identity of their cognate receptors, the roles of PUFA-derived signaling lipids require more investigation. In addition, PUFA functions cannot be explained just as lipid mediator precursors because they are also critical for the regulation of membrane biophysical properties. The presence of PUFAs in membrane lipids also affects the functions of transmembrane proteins and peripheral membrane proteins. Although the roles of PUFAs as membrane lipid building blocks were difficult to analyze, the discovery of lysophospholipid acyltransferases (LPLATs), which are critical for their incorporation, advanced our understanding. Recent studies unveiled how LPLATs affect PUFA levels in membrane lipids, and their genetic manipulation became an excellent strategy to study the roles of PUFA-containing lipids. In this review, we will provide an overview of metabolic pathways regulating PUFAs as lipid mediator precursors and membrane components and update recent progress about their functions. Some issues to be solved for future research will also be discussed.</p>
</abstract>
<kwd-group>
<kwd>membrane biology</kwd>
<kwd>eicosanoids</kwd>
<kwd>G protein-coupled receptors</kwd>
<kwd>membrane biophysics</kwd>
<kwd>glycerophospholipids</kwd>
</kwd-group>
<funding-group>
<award-group id="sp1">
<funding-source>
<institution-wrap>
<institution>Japan Agency for Medical Research and Development</institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100009619</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="sp2">
<funding-source>
<institution-wrap>
<institution>Takeda Science Foundation</institution>
<institution-id institution-id-type="open-funder-registry">10.13039/100007449</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="sp3">
<funding-source>
<institution-wrap>
<institution>Swiss National Science Foundation</institution>
<institution-id institution-id-type="open-funder-registry">10.13039/501100001711</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group id="sp4">
<funding-source>
<institution-wrap>
<institution>Japan Society for the Promotion of Science</institution>
<institution-id institution-id-type="open-funder-registry">10.13039/501100001691</institution-id>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
<body>
<p>The importance of PUFAs in health and disease gained general attention, as exemplified by the belief that eating more ω-3 PUFAs is good for health. PUFAs are fatty acids that have two or more double bonds, which can be illustrated as XX:Yω-Z (XX, Y, and Z are carbon number, double bond number, and the position of the first double bond from the methyl end, respectively). They cannot be synthesized endogenously in mammals, except for mead acid (20:3ω-9), which is produced under PUFA deficiency (<xref ref-type="bibr" rid="b1">1</xref>). Therefore, PUFAs are essential nutrients that have to be obtained from the diet. While important PUFAs, such as AA (20:4ω-6) and DHA (22:6ω-3), can be directly taken up from the diet, they can also be converted from other PUFAs endogenously. The liver has a major contribution in this process, where dietary linoleic acid (LA; 18:2ω-6) and α-linolenic acid (18:3ω-3) are metabolized into other PUFAs by desaturases, elongases, and peroxisomal β-oxidation (<xref ref-type="bibr" rid="b2">2</xref>) (<xref ref-type="fig" rid="f1"><bold>Fig. 1A</bold></xref>). Peroxisomes are critical for the final step of DHA synthesis, and their dysfunction leads to the accumulation of the otherwise minor intermediate PUFA, tetracosahexaenoic acid (24:6ω-3) (<xref ref-type="bibr" rid="b3">3</xref>). Analysis of mice lacking elongases or desaturases revealed PUFA functions in brain, metabolic tissues, reproductive organs, and blood cells (<xref ref-type="bibr" rid="b4">4</xref>–<xref ref-type="bibr" rid="b13">13</xref>). While some of the phenotypes of these mice were seen only when fed PUFA-deficient diets, others, such as the lean phenotype of <italic>Fads1</italic>-deficient mice (<xref ref-type="bibr" rid="b14">14</xref>), were observed even when the diets were PUFA sufficient (<xref ref-type="bibr" rid="b7">7</xref>). This supports the importance of obtaining sufficient levels of PUFAs both from the diet and from endogenous conversion. Importantly, the possibility to rescue the phenotypes by dietary intervention was dependent on which PUFA to give, clearly demonstrating the nonredundancy in their functions (<xref ref-type="table" rid="t1"><bold>Table 1</bold></xref>). The importance of PUFAs has also been analyzed by feeding them in cell culture, revealing important roles in osteogenesis (<xref ref-type="bibr" rid="b15">15</xref>) and mechanosensing (<xref ref-type="bibr" rid="b16">16</xref>), among many others. While such in vivo and in cellulo experiments support the biological importance of PUFAs, understanding the molecular mechanisms of PUFA functions remains challenging.</p>
<fig fig-type="figure" id="f1" orientation="portrait" position="float">
<label>Fig. 1.</label>
<caption>
<p>Synthesis and metabolism of PUFAs. A: PUFA conversion from the essential fatty acids, LA and α-linolenic acid (ALA), by the indicated enzymes. FADS2 is proposed to desaturate other positions as well (<xref ref-type="bibr" rid="b115">115</xref>), which is not depicted here. “XX:Yω-Z” illustrates a PUFA with XX carbons, Y double bonds, and the first double bond at the Zth carbon from the methyl end. Note the absence of inter-conversion between ω-6 and ω-3 PUFAs. B: Synthesis of GPLs from glycerol 3-phosphate (G3P), and generation of lipid mediators thereof. Arrows with numbers illustrate steps where free fatty acids (FFAs) are generated (arrow 1, PLA<sub>2</sub>; arrow 2, TAG lipase; and arrow 3, MAG lipase), which can be further used to generate PUFA-derivatives. For simplicity, acyl-chain remodeling (Lands’ cycle) is illustrated only for PC and PI, but the pathway is functional for other GPLs as well. The LPLATs important for PUFA incorporation are illustrated. Although the presence of a LPAAT important for LA accumulation is suggested (<xref ref-type="bibr" rid="b72">72</xref>), the responsible gene is unknown (indicated as “x” here). Cofactors and byproducts of enzymatic reactions are omitted. AGPAT3 and MBOAT7 are also termed LPAAT3 and LPIAT1, respectively. CDP-DAG, cytidine diphosphate-diacylglycerol; CL, cardiolipin; DAG, diacylglycerol; LPA, lysoPA; MAG, monoacylglycerol; NAE, N-acylethanolamine; NAPE, N-acyl PE; PI(4,5)P2, PI 4,5-bisphosphate; PI4P, PI 4-phosphate; SAG, stearoyl-arachidonoyl glycerol; TAG, triacylglycerol.</p>
</caption>
<graphic xlink:href="1150fig1"></graphic>
</fig>
<table-wrap id="t1" orientation="portrait" position="float">
<label>TABLE 1.</label>
<caption>
<p>Phenotypes of mice lacking the enzymes of <xref ref-type="fig" rid="f1">Fig. 1A</xref> (not exhaustive) or LPLATs involved in the incorporation of PUFAs into membrane GPLs</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<td colspan="1" rowspan="1">Gene</td>
<td colspan="1" rowspan="1">Tissue</td>
<td align="center" colspan="1" rowspan="1">PUFAs Decreased</td>
<td align="center" colspan="1" rowspan="1">PUFAs Increased</td>
<td colspan="1" rowspan="1">Phenotype</td>
<td align="center" colspan="1" rowspan="1">Rescued By</td>
<td align="center" colspan="1" rowspan="1">Not Rescued By</td>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="4">Elovl2</td>
<td colspan="1" rowspan="1">Testis</td>
<td align="center" colspan="1" rowspan="1">22:5ω-6, 22:6ω-3, 24:5ω-6, 26:5ω-6, 28:5ω-6, 30:5ω-6</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6, 22:4ω-6</td>
<td colspan="1" rowspan="1">Sterility</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">22:6ω-3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Liver</td>
<td align="center" colspan="1" rowspan="1">22:5ω-6, 22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6, 20:5ω-3, 22:4ω-6, 22:5ω-3</td>
<td colspan="1" rowspan="1">Prevention of hepatic steatosis</td>
<td align="center" colspan="1" rowspan="1">22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Liver</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">High nuclear SREBP-1c</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">22:6ω-3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Macrophages</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Changes in inflammatory profiles</td>
<td align="center" colspan="1" rowspan="1">22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Elovl5</td>
<td colspan="1" rowspan="1">Liver</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6, 20:5ω-3, 22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">18:2ω-6, 18:3ω-3, 18:4ω-3</td>
<td colspan="1" rowspan="1">Hepatic steatosis</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6, 22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Fads1</td>
<td colspan="1" rowspan="1">Whole body</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6</td>
<td align="center" colspan="1" rowspan="1">20:3ω-6</td>
<td colspan="1" rowspan="1">Lethality</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="8">Fads2</td>
<td colspan="1" rowspan="1">Platelets</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Reduced thromboembolism</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ovary</td>
<td align="center" colspan="1" rowspan="1">20:4, 22:6, 24:5</td>
<td align="center" colspan="1" rowspan="1">18:2, 20:2</td>
<td colspan="1" rowspan="1">Sterility</td>
<td align="center" colspan="1" rowspan="1">20:5ω-3 + 22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Testis</td>
<td align="center" colspan="1" rowspan="1">20:4, 22:5, 22:6, 24:5, 26:5, 28:5, 30:5</td>
<td align="center" colspan="1" rowspan="1">18:2</td>
<td colspan="1" rowspan="1">Sterility</td>
<td align="center" colspan="1" rowspan="1">20:5ω-3 + 22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Skin, intestine</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Ulcer formation</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Testis</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6, 20:5ω-3, 22:4ω-6, 22:5ω-6, 22:6ω-3, 26:5ω-6, 28:5ω-6, 30:5ω-6</td>
<td align="center" colspan="1" rowspan="1">20:3(Δ7,11,14)</td>
<td colspan="1" rowspan="1">Sterility</td>
<td align="center" colspan="1" rowspan="1">22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6 (partial)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Liver</td>
<td align="center" colspan="1" rowspan="1">20:4, 22:6</td>
<td align="center" colspan="1" rowspan="1">18:2, 20:3</td>
<td colspan="1" rowspan="1">Hepatic steatosis</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6</td>
<td align="center" colspan="1" rowspan="1">22:6ω-3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Whole body</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Weight loss</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6</td>
<td align="center" colspan="1" rowspan="1">22:6ω-3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Brain</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6, 22:4ω-6, 22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">18:2ω-6</td>
<td colspan="1" rowspan="1">Decreased brain functions</td>
<td align="center" colspan="1" rowspan="1">22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">20:4ω-6 (partial)</td>
</tr>
<tr>
<td colspan="1" rowspan="2">Agpat3/Lpaat3</td>
<td colspan="1" rowspan="1">Testis</td>
<td align="center" colspan="1" rowspan="1">22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Sterility</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Retina</td>
<td align="center" colspan="1" rowspan="1">22:6ω-3</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Blindness</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="8">Lpcat3</td>
<td colspan="1" rowspan="1">Small intestine</td>
<td align="center" colspan="1" rowspan="1">18:2ω-6, 20:4ω-6</td>
<td align="center" colspan="1" rowspan="1">22:4ω-6, 22:5ω-6, 22:6ω-3</td>
<td colspan="1" rowspan="1">Neutral lipid overaccumulation</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Small intestine</td>
<td align="center" colspan="1" rowspan="1">18:2, 18:3, 20:4</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Neutral lipid overaccumulation</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Intestinal stem cells</td>
<td align="center" colspan="1" rowspan="1">18:2, 20:4</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Cholesterol overproduction, overproliferation</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Embryonic liver</td>
<td align="center" colspan="1" rowspan="1">18:2ω-6, 20:3ω-6, 20:4ω-6</td>
<td align="center" colspan="1" rowspan="1">22:4ω-6, 22:5ω-6, 22:6ω-3</td>
<td colspan="1" rowspan="1">Neutral lipid overaccumulation</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Liver</td>
<td align="center" colspan="1" rowspan="1">20:4</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Reduced neutral lipid secretion</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Liver</td>
<td align="center" colspan="1" rowspan="1">20:4</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Reduced nuclear SREBP-1c</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hematopoietic cells</td>
<td align="center" colspan="1" rowspan="1">20:4, 20:5</td>
<td align="center" colspan="1" rowspan="1">22:4</td>
<td colspan="1" rowspan="1">Increased cholesterol, promotion of atherosclerosis</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Myeloid cells</td>
<td align="center" colspan="1" rowspan="1">20:4</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Altered cytokine profile</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mboat7/Lpiat1</td>
<td colspan="1" rowspan="1">Brain</td>
<td align="center" colspan="1" rowspan="1">20:4</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td colspan="1" rowspan="1">Brain malformation, fatty liver</td>
<td align="center" colspan="1" rowspan="1">—</td>
<td align="center" colspan="1" rowspan="1">—</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Only phenotypes that were tested for rescue by dietary PUFAs are listed in the case for elongases and desaturases.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>PUFAs have two major modes of action: precursors of signaling lipids (lipid mediators) and building blocks of membrane lipids (<xref ref-type="bibr" rid="b17">17</xref>). It is thus important to recognize the pleiotropic functions of PUFAs and dissect their modes of action. This necessity made PUFA research an exciting multidisciplinary field at the interface of biology, biophysics, and chemical biology. Here, we will highlight the complex metabolism of PUFAs, the investigation of which elucidated PUFA functions, as lipid mediators and in membranes.</p>
<sec>
<title>PUFA-DERIVATIVES IN SIGNALING</title>
<p>Multiple lipid mediators are produced downstream of glycerophospholipid (GPL) synthesis (<xref ref-type="fig" rid="f1">Fig. 1B</xref>). They include metabolites of PUFAs (e.g., eicosanoids, docosanoids) and lipids with esterified PUFAs [e.g., 2-arachidonoylglycerol (2-AG)], collectively termed PUFA-derivatives here (<xref ref-type="fig" rid="f2"><bold>Fig. 2A</bold></xref>).</p>
<fig fig-type="figure" id="f2" orientation="portrait" position="float">
<label>Fig. 2.</label>
<caption>
<p>PUFA-derivatives as ligands and their receptors. A: Structures of selected PUFA-derivatives. Prostaglandin E<sub>2</sub> (ligand for EP1-EP4), leukotriene B<sub>4</sub> (ligand for BLT1), and 12-hydroxyheptadecatrienoic acid (ligand for BLT2) are metabolites of AA. 2-Arachidonoyl lysophosphatidylinositol (ligand for GPR55), 2-arachidonoyl glycerol, and anandamide (both ligands for CB1 and CB2) contain AA in the esterified form. 13-DHAHLA was recently discovered and its receptor is unknown. B: Phylogenetic tree of selected GPCRs, with emphasis on those that use lipids as ligands. The nomenclature and phylogenetic tree analysis of receptors is based on GPCRdb (<ext-link ext-link-type="uri" xlink:href="https://gpcrdb.org">https://gpcrdb.org</ext-link>). Smaller symbols represent receptors of which the name does not reflect the proposed lipid ligand. Replication studies are especially important for these receptors. Note that some of the proteins not classified as “PUFA-derivative” receptors can still use PUFA-derivatives as ligands (e.g., some lysophosphatidic acid receptors can sense PUFA-containing molecules), although they do not sense PUFA-derivatives exclusively.</p>
</caption>
<graphic xlink:href="1150fig2"></graphic>
</fig>
<sec>
<title>Diversity of PUFA-derivatives</title>
<p>AA is mainly esterified at the <italic>sn-</italic>2 position of GPLs, such as PC, PE, PS, phosphatidylglycerol, and PI. PI is especially rich in AA (with stearic acid at the <italic>sn-</italic>1 position), while other GPLs have more diverse acyl-chains (<xref ref-type="bibr" rid="b18">18</xref>). After being released from GPLs by phospholipase A<sub>2</sub> (PLA<sub>2</sub>) enzymes (<xref ref-type="fig" rid="f1">Fig. 1B</xref>, arrow 1), AA is converted into more than a hundred different lipid mediators (eicosanoids) by cyclooxygenases, lipoxygenases, cytochrome P450 enzymes, and specific synthases (<xref ref-type="bibr" rid="b17">17</xref>). Among PLA<sub>2</sub>s, cytosolic PLA<sub>2</sub>α (cPLA<sub>2</sub>α) causes translocation from cytosol to perinuclear membranes upon various stimuli and is especially important for eicosanoid production (<xref ref-type="bibr" rid="b19">19</xref>). Analyses of cPLA<sub>2</sub>α using hydrogen/deuterium exchange mass spectrometry and molecular dynamics revealed how the enzyme uses its C2 domain to bind membranes upon calcium binding (<xref ref-type="bibr" rid="b20">20</xref>, <xref ref-type="bibr" rid="b21">21</xref>), to which atomistic details were brought by a recent structural analysis of the C2 domain complexed with a PC membrane (<xref ref-type="bibr" rid="b19">19</xref>). In addition to perinuclear membranes, cPLA<sub>2</sub>α localizes to the base of primary cilia, where it releases AA to regulate ciliary trafficking of Smoothened, the signal transducer of the Sonic Hedgehog pathway (<xref ref-type="bibr" rid="b22">22</xref>). Mice lacking cPLA<sub>2</sub>α have drastic decreases in eicosanoids and are protected from disease models that include anaphylaxis, asthma, and experimental allergic encephalomyelitis (<xref ref-type="bibr" rid="b17">17</xref>). However, they also display abnormalities in labor and synaptic plasticity, demonstrating the pleiotropy of eicosanoid functions (<xref ref-type="bibr" rid="b23">23</xref>, <xref ref-type="bibr" rid="b24">24</xref>). The implication of other phospholipases in the release of PUFAs from GPLs is well recapitulated in another review (<xref ref-type="bibr" rid="b25">25</xref>). While AA release from GPLs has been studied intensively, other sources of AA for eicosanoid synthesis have been documented, such as triglycerides and 2-AG (<xref ref-type="bibr" rid="b26">26</xref>, <xref ref-type="bibr" rid="b27">27</xref>) (<xref ref-type="fig" rid="f1">Fig. 1B</xref>, arrows 2 and 3). Eicosanoids produced downstream of the hydrolysis of 2-AG (which is also a lipid mediator) by monoacylglycerol lipase are especially important in the brain, with implications in neuroinflammation and fever responses (<xref ref-type="bibr" rid="b27">27</xref>, <xref ref-type="bibr" rid="b28">28</xref>). Blockade of this pathway reduces eicosanoid production and ameliorates a mouse model of Alzheimer’s disease (<xref ref-type="bibr" rid="b29">29</xref>). This pathway is also active outside the brain, as has been shown in a model of hepatic injury (<xref ref-type="bibr" rid="b30">30</xref>). PI, being rich in AA, is a good source of 2-AG, and might feed efficiently into this pathway (<xref ref-type="fig" rid="f1">Fig. 1B</xref>).</p>
<p>Eicosanoids are only one part of the diverse repertoire of PUFA-derivatives; other PUFAs are converted into lipid mediators through similar pathways. Those generated from the ω-3 PUFAs, EPA and DHA, are generally regarded as pro-resolving lipid mediators, in contrast to the pro-inflammatory eicosanoids (<xref ref-type="bibr" rid="b31">31</xref>, <xref ref-type="bibr" rid="b32">32</xref>). This view is oversimplified though, and some ω-3 PUFA-derivatives promote allergic responses while the eicosanoid lipoxin A<sub>4</sub> is pro-resolving (<xref ref-type="bibr" rid="b31">31</xref>–<xref ref-type="bibr" rid="b33">33</xref>). Recent investigations revealed important roles of the secreted PLA<sub>2</sub> group 2D (PLA2G2D) in the release of PUFAs, including ω-3 PUFAs, from extracellular GPL substrates to generate pro-resolving lipid mediators. PLA2G2D deficiency reduces the production of pro-resolving lipid mediators in the lymph nodes and delays the resolution of contact dermatitis in mice (<xref ref-type="bibr" rid="b34">34</xref>). In addition, DHA released by M2-type macrophage-derived PLA2G2D in adipose tissues promotes the generation of beige adipocytes (<xref ref-type="bibr" rid="b35">35</xref>). DHA acts as a ligand for free fatty acid receptor 4, which is expressed in primary cilia of preadipocytes and regulates adipogenesis (<xref ref-type="bibr" rid="b36">36</xref>). Thus, the ω-3 PUFA DHA has various effects on adipocyte functions. Together with its anti-inflammatory function on macrophages (<xref ref-type="bibr" rid="b37">37</xref>), the pleiotropic roles of DHA as a lipid mediator contribute to metabolic health.</p>
<p>Lipid mediators containing esterified PUFAs are also numerous, such as the cannabinoid receptor ligands 2-AG and anandamide (<italic>N</italic>-arachidonoylethanolamine). They mediate retrograde signaling in neuronal synapses and regulate appetite and pain, while having peripheral functions in the immune system as well (<xref ref-type="bibr" rid="b38">38</xref>, <xref ref-type="bibr" rid="b39">39</xref>). Another example is 2-arachidonoyl LPI, which is synthesized from PI via the action of phospholipase A<sub>1</sub> (<xref ref-type="bibr" rid="b40">40</xref>). One of its functions is to regulate lymphocyte migration as a ligand for the G protein-coupled receptor (GPCR) GPR55 (<xref ref-type="bibr" rid="b41">41</xref>). In addition to this already exhaustive list, novel PUFA-derivatives and synthetic pathways are continuously discovered, such as the hemiketal eicosanoids and fatty acid esters of hydroxy fatty acids (FAHFAs) (<xref ref-type="bibr" rid="b42">42</xref>, <xref ref-type="bibr" rid="b43">43</xref>).</p>
</sec>
<sec>
<title>Signaling by PUFA-derivatives</title>
<p>PUFA-derivatives signal through their receptors, which include GPCRs, ion channels, and nuclear receptors (the last two tend to be more promiscuous). So far, many GPCRs are proposed as PUFA-derivative receptors (<xref ref-type="fig" rid="f2">Fig. 2B</xref>), but conflicting results are often reported between studies using different assays (<xref ref-type="bibr" rid="b44">44</xref>, <xref ref-type="bibr" rid="b45">45</xref>), and some might be invalidated in the future. In addition, the presence of multiple receptors for the same ligand [e.g., four prostaglandin E<sub>2</sub> receptors (<xref ref-type="bibr" rid="b46">46</xref>)] or the presence of nonlipid ligands for proposed lipid receptors [e.g., GPR132, also termed G2A, reported to be a proton sensor (<xref ref-type="bibr" rid="b47">47</xref>) and a receptor for 9-hydroxyoctadecadienoic acid (<xref ref-type="bibr" rid="b48">48</xref>); chemerin being a protein ligand for the proposed receptor of resolvin E<sub>1</sub> (<xref ref-type="bibr" rid="b49">49</xref>)] should be taken into account when considering the functions of PUFA-derivatives. For example, GPR37 is proposed as the receptor for DHA-derived neuroprotective and anti-inflammatory protectin D1 (<xref ref-type="bibr" rid="b50">50</xref>), while the peptide prosaptide also acts through the same receptor and has similar neuroprotective roles (<xref ref-type="bibr" rid="b51">51</xref>). Therefore, it will be important for future studies, especially for PUFA-derivatives that do not have a long history of research, to investigate whether the effects of receptor blockade correspond to those of interference with ligand synthesis.</p>
<p>For PUFA-derivatives having well-validated receptors, such as the eicosanoid prostaglandin E<sub>2,</sub> genetic disruption or inhibitors can be used to investigate in vivo functions. Prostaglandin E<sub>2</sub> has been implicated in colon cancer through multiple genetic studies, with consistent phenotypes between mutant mice of synthetic enzymes (<xref ref-type="bibr" rid="b52">52</xref>, <xref ref-type="bibr" rid="b53">53</xref>) and receptors (<xref ref-type="bibr" rid="b54">54</xref>). In a recent study, single-cell RNA sequencing was used to identify a rare fibroblast population producing prostaglandin E<sub>2</sub>, which promotes tumor initiation by activating Yap nuclear localization in stem cells that are in proximity (<xref ref-type="bibr" rid="b55">55</xref>). In the same study, fibroblast-produced prostaglandin E<sub>2</sub> was shown to be part of a regenerative program after intestinal damage, thereby revealing the correct biological functions of this lipid mediator. With reliable information about synthetic enzymes and receptors, single-cell RNA sequencing approaches might be used similarly in different contexts to identify PUFA-derivative functions.</p>
<p>Our understanding of PUFA-derivative signaling advanced especially in the context of structural biology. The number of reported GPCR structures is expanding, such as the crystal structures of leukotriene B<sub>4</sub> receptor BLT1 and the prostaglandin D<sub>2</sub> receptor DP2 (<xref ref-type="bibr" rid="b56">56</xref>, <xref ref-type="bibr" rid="b57">57</xref>). The structure of prostaglandin E<sub>2</sub> receptor EP3 was solved in the presence of its endogenous ligand, revealing critical insights into ligand recognition (<xref ref-type="bibr" rid="b58">58</xref>). Molecular docking and molecular dynamics simulations have also been used to investigate the recognition of endogenous ligands for other receptors (<xref ref-type="bibr" rid="b59">59</xref>, <xref ref-type="bibr" rid="b60">60</xref>). The structure of the cannabinoid receptor CB1 has been solved in multiple states, bound to inverse agonists, antagonists, agonists, and allosteric modulators or in complex with trimeric G<sub>i</sub> protein, revealing the structural rearrangements upon ligand binding that lead to signaling events (<xref ref-type="bibr" rid="b59">59</xref>, <xref ref-type="bibr" rid="b61">61</xref>–<xref ref-type="bibr" rid="b64">64</xref>). The structural characteristics of some GPCRs (e.g., DP2, EP4, TP, and LPA6), such as the presence of an occluded extracellular surface and side openings between transmembrane helices, suggested that the amphiphilic lipid ligands reach the receptor by lateral diffusion in the plasma membrane rather than directly from outside of the cells (<xref ref-type="bibr" rid="b57">57</xref>, <xref ref-type="bibr" rid="b60">60</xref>, <xref ref-type="bibr" rid="b65">65</xref>, <xref ref-type="bibr" rid="b66">66</xref>). On the other hand, BLT1 ligand binding pocket is open on the extracellular surface (<xref ref-type="bibr" rid="b56">56</xref>), thus different lipid ligands reach their receptors in distinct ways. It will be interesting to understand how these different receptor-accessing modes affect the functions of PUFA-derivatives, such as their effective concentrations, the recognition of their concentration gradients, and their autocrine or paracrine behavior.</p>
<p>To conclude, signaling by PUFA-derivatives is complex due to their diversity, the presence of multiple synthetic sources, and the multiple receptors of a single ligand. Nevertheless, genetic studies of enzymes and receptors unveiled various roles of PUFA-derivatives (<xref ref-type="bibr" rid="b17">17</xref>, <xref ref-type="bibr" rid="b46">46</xref>, <xref ref-type="bibr" rid="b67">67</xref>, <xref ref-type="bibr" rid="b68">68</xref>), and structural analyses revealed atomistic insights of their functions. Methodological advances are ongoing to detect lipid mediators comprehensively (<xref ref-type="bibr" rid="b69">69</xref>) and to unveil the spatiotemporal regulation of receptor activation in vivo (<xref ref-type="bibr" rid="b70">70</xref>). It will be important to solve controversies regarding the assignment PUFA-derivative receptors, and researchers are encouraged to publish more replication studies (both positive and negative). With more reliability in receptors, we will be able to understand the degree to which PUFAs affect pathophysiological conditions as lipid mediator precursors, which might reveal novel therapeutic targets.</p>
</sec>
</sec>
<sec>
<title>MEMBRANE PUFAS</title>
<sec>
<title>Regulation of PUFA-GPLs</title>
<p>While dietary uptake affects whole-organism PUFA supply, tissue-specific functions of GPLs containing PUFAs (PUFA-GPLs) require factors that regulate their tissue distribution. The incorporation of PUFAs at the GPL <italic>sn-</italic>2 position, their main localization, is catalyzed by lysophospholipid acyltransferases (LPLATs) (<xref ref-type="fig" rid="f1">Fig. 1B</xref>, bold arrows). These enzymes use lyso-GPLs and acyl-CoAs as substrates. During GPL de novo synthesis, lysophosphatidic acid acyltransferases (LPAATs) are the LPLATs that acylate the <italic>sn-</italic>2 position and generate the common precursor PA, which is further converted to other GPLs. Acyl-chains of individual GPLs can be remodeled in the “Lands’ cycle,” where one acyl-chain is removed and another one is reincorporated by other LPLATs (<xref ref-type="bibr" rid="b71">71</xref>, <xref ref-type="bibr" rid="b72">72</xref>).</p>
<p>At least for PC (the most abundant GPL), expression levels of LPLATs contribute to tissue differences in PUFA-GPL levels, where LPAATs and other LPLATs have different roles. LPAATs enable the accumulation of LA and DHA in PC (and possibly to other GPLs), while AA is mainly incorporated during the Lands’ cycle (<xref ref-type="bibr" rid="b72">72</xref>, <xref ref-type="bibr" rid="b73">73</xref>). This conclusion is based on the correlation between PC acyl-chain composition and LPLAT substrate selectivity in various tissues (<xref ref-type="bibr" rid="b72">72</xref>), which was later validated in part by genetic studies (<xref ref-type="bibr" rid="b72">72</xref>–<xref ref-type="bibr" rid="b75">75</xref>). Indeed, disruption of the DHA-preferring AGPAT3 (also termed LPAAT3) drastically reduces DHA-containing GPLs (DHA-GPLs) (<xref ref-type="bibr" rid="b74">74</xref>, <xref ref-type="bibr" rid="b75">75</xref>), while loss of the Lands’ cycle LPLATs, LPCAT3, and MBOAT7 (also termed LPIAT1) lowers AA levels in PC, PE, PS, and PI, respectively (<xref ref-type="bibr" rid="b73">73</xref>, <xref ref-type="bibr" rid="b76">76</xref>). Enzyme activity measurements suggest the presence of LPAAT enzyme(s) regulating LA levels (<xref ref-type="bibr" rid="b72">72</xref>), but the molecular identity of the enzyme(s) remains to be identified. Thus, LPLATs regulate PUFA levels and tissue distribution, with clearly distinct contribution depending on the individual PUFA. High AA levels in PI might assist the PI cycle (<xref ref-type="fig" rid="f1">Fig. 1B</xref>), where the PI head group is sequentially modified for signaling purposes, because some enzymes of the cycle prefer AA-containing substrates (<xref ref-type="bibr" rid="b18">18</xref>).</p>
<p>While it is clear that LPLATs have a strong impact on the levels of PUFAs found in GPLs of different tissues, factors that affect tissue supply of PUFAs also exist. For example, MFSD2A is a lipid transporter required for DHA accretion in the brain. Importantly, MFSD2A does not transport free DHA, but rather lyso-PC that contains DHA (DHA-lyso-PC) (<xref ref-type="bibr" rid="b77">77</xref>). Thus, DHA-lyso-PC in the bloodstream is a critical source for brain DHA. While such a selectivity was already reported (<xref ref-type="bibr" rid="b78">78</xref>), the identification of MFSD2A provided clear molecular mechanisms. Strategies for improved DHA delivery to the brain are developing based on this discovery (<xref ref-type="bibr" rid="b79">79</xref>, <xref ref-type="bibr" rid="b80">80</xref>), which might be tested for a therapeutic potential in neuronal diseases where DHA levels are decreased. Another factor affecting brain DHA levels is PE methyltransferase, which converts PE into PC in the liver (<xref ref-type="bibr" rid="b81">81</xref>). PE methyltransferase has preference to DHA-containing PE (DHA-PE). Thus, DHA delivery to the brain is a multistep process, requiring the conversion of DHA-PE into DHA-PC in the liver, and then its conversion into DHA-lyso-PC, which is finally taken up by MFSD2A. The mechanisms regulating DHA-PE levels and the enzymes required for DHA-lyso-PC synthesis remain to be clarified. For the latter, phospholipase A<sub>1</sub> activity would be required, for which hepatic lipase and endothelial lipase are good candidates (<xref ref-type="bibr" rid="b80">80</xref>). The identification of other factors affecting tissue-specific PUFA uptake will be of great relevance. For example, fatty acid transporter protein 2 was recently found to affect AA uptake in neutrophils (<xref ref-type="bibr" rid="b82">82</xref>). It will be important to investigate how specifically this transporter and other related ones affect PUFA levels in various tissues.</p>
</sec>
<sec>
<title>Mechanisms of PUFA functions in membranes</title>
<p>PUFAs in GPLs have a higher structural plasticity than saturated fatty acids or MUFAs and can adopt highly kinked shapes. Consequently, PUFA-GPLs increase membrane disorder and affect their physical properties (<xref ref-type="bibr" rid="b83">83</xref>) (<xref ref-type="fig" rid="f3"><bold>Fig. 3A</bold>–D</xref>). Because MUFAs also induce disorder, we need to discuss PUFA functions with care and evaluate whether their effects on membrane physical properties differ from those of MUFAs in a biologically relevant manner. Also, PUFA-GPLs affect many physical properties simultaneously, and it remains difficult to know which ones, or which combinations of them, are important.</p>
<fig fig-type="figure" id="f3" orientation="portrait" position="float">
<label>Fig. 3.</label>
<caption>
<p>Physical properties of membranes affected by PUFA-containing GPLs. A: Color coding of GPLs. In this illustration, all the GPLs have a saturated acyl-chain at the <italic>sn-</italic>1 position, as is mainly seen in cells. B: Membranes with fewer unsaturated GPLs tend to be thicker (and less fluid) than those with more unsaturated GPLs, due to the higher order in the acyl-chains. Here, we assume the presence of unsaturated GPLs in both cases, to a level that prevents the formation of a gel phase. C: Unsaturated GPLs promote the formation of packing defects, which are water-accessible voids in membrane hydrophobic regions. Packing defects are more abundant in bent membranes not depicted here. The depth of packing defects tends to be shallower in the presence of PUFA-GPLs (arrows). Packing defects promote membrane binding of protein amphipathic helices, and their depth affects the selectivity of this interaction. Shallower defects accommodate amphipathic helices with less bulky hydrophobic side chains. D: PUFA-GPLs, when present in the convex leaflet of a bent membrane, decrease bending rigidity. E: Acyl-chains of GPLs affect the depth-dependent pressure profile exerted on neighboring molecules (lateral pressure profile), which can affect transmembrane protein functions.</p>
</caption>
<graphic xlink:href="1150fig3"></graphic>
</fig>
<sec>
<title>Fluidity.</title>
<p>PUFA-GPLs are thought to increase membrane fluidity. While this is often proposed as a mechanism for PUFA functions, it is rarely shown quantitatively that the gain of fluidity (here defined as the speed of molecules’ diffusion and rotation) by PUFAs (compared with MUFAs) is sufficient to explain a phenomenon. The role of PUFAs in fluidity regulation has even been questioned (<xref ref-type="bibr" rid="b84">84</xref>). A recent study combined theoretical and experimental approaches to demonstrate that bacterial respiration is a diffusion-limited process and that MUFAs have quantitatively enough impact on this process (<xref ref-type="bibr" rid="b85">85</xref>). In another study, researchers combined reconstitution assays, biophysical measurements, and molecular dynamics simulations, and found that the yeast sensor for membrane unsaturation and transcription factor Mga2 is not affected by fluidity per se but rather by depth-dependent membrane packing (<xref ref-type="bibr" rid="b86">86</xref>). This study is a good example of why it is oversimplified to explain all the functions of unsaturated lipids through membrane fluidity. Therefore, future investigations about PUFA functions that rely on fluidity should be conducted carefully, as was done in the aforementioned studies.</p>
</sec>
<sec>
<title>Thickness.</title>
<p>The disorder induced by PUFA-GPLs and MUFA-GPLs makes membranes thinner when compared with saturated fatty acid-GPLs (<xref ref-type="fig" rid="f3">Fig. 3B</xref>). Membrane thickness affects the localization and function of transmembrane proteins, which is a possible mechanism for PUFA functions (<xref ref-type="bibr" rid="b87">87</xref>). It should be noted that highly unsaturated PUFAs are often longer than MUFAs, thus PUFA-GPLs do not necessarily make membranes thinner than MUFA-GPLs do (<xref ref-type="bibr" rid="b88">88</xref>).</p>
</sec>
<sec>
<title>Packing defects.</title>
<p>Packing defects are water-accessible voids in the hydrophobic part of membranes, which accumulate in the presence of unsaturated lipids or conical lipids, or upon membrane bending (<xref ref-type="fig" rid="f3">Fig. 3C</xref>). Protein amphipathic helices can interact with membranes through packing defects, which is used as a strategy to sense vesicles with different lipid compositions (<xref ref-type="bibr" rid="b89">89</xref>). While GPLs with MUFAs or PUFAs both generate packing defects, PUFA-GPLs make shallower ones, due to their structural flexibility (<xref ref-type="bibr" rid="b90">90</xref>). The depth of packing defects affects the binding of amphipathic helices with various side chains; thus PUFA-GPLs might regulate protein-membrane interactions.</p>
</sec>
<sec>
<title>Bending rigidity.</title>
<p>PUFA-GPLs make membranes more flexible than MUFA-GPLs (<xref ref-type="bibr" rid="b91">91</xref>) (<xref ref-type="fig" rid="f3">Fig. 3D</xref>). This is attributable to the ability to reduce packing defects upon bending (and possibly to thickness). Thus, PUFAs affect processes where membrane bending occurs, as has been shown for endocytosis (<xref ref-type="bibr" rid="b90">90</xref>). Bending rigidity is a plausible mechanism for in vivo PUFA functions, as will be explained later. Importantly, only PUFA-GPLs present at the convex leaflet of a bent membrane reduce rigidity (<xref ref-type="bibr" rid="b91">91</xref>), which is consistent with the asymmetrical distribution of PUFA-GPLs in the plasma membrane (<xref ref-type="bibr" rid="b92">92</xref>), if considering endocytosis.</p>
</sec>
<sec>
<title>Protein conformation.</title>
<p>Lateral pressure profiles illustrate local forces that are applied, for example to a membrane protein, depending on the depth in the membrane. Double bond positions in GPLs affect this property, which can change membrane protein conformation (<xref ref-type="bibr" rid="b93">93</xref>) (<xref ref-type="fig" rid="f3">Fig. 3E</xref>). The conformational flexibility of PUFAs could also assist dynamic changes in membrane protein conformation (<xref ref-type="bibr" rid="b83">83</xref>).</p>
</sec>
<sec>
<title>Chemical properties.</title>
<p>Not only the physical properties but also the chemical properties (e.g., oxidative property) of PUFA-GPLs mediate their functions. One example is ferroptosis, which is a form of cell death triggered by peroxidized PUFA-GPLs and is investigated as a potential anti-cancer strategy (<xref ref-type="bibr" rid="b94">94</xref>).</p>
</sec>
</sec>
<sec>
<title>Roles of membrane PUFAs</title>
<p>Many functions of PUFA-GPLs were unveiled through LPLAT research (<xref ref-type="table" rid="t1">Table 1</xref>) (<xref ref-type="bibr" rid="b73">73</xref>–<xref ref-type="bibr" rid="b76">76</xref>, <xref ref-type="bibr" rid="b95">95</xref>–<xref ref-type="bibr" rid="b103">103</xref>). AGPAT3-deficient mice, which have reduced DHA-GPLs, display spermatogenesis defects and retinal dysfunctions (<xref ref-type="bibr" rid="b74">74</xref>, <xref ref-type="bibr" rid="b75">75</xref>). Indirect evidence suggests that DHA-GPLs, by reducing bending rigidity, promote the formation of strongly bent membranes during spermatogenesis (for the removal of cytoplasm by Sertoli cells by tubulobulbar complex) and during maturation of rhodopsin-containing retinal disc membranes, although the role of DHA-derived lipid mediators (collectively termed docosanoids) in these processes is also possible.</p>
<p>LPCAT3-deficient mice have specific reductions in GPLs containing AA (AA-GPLs) and are neonatally lethal due to enterocyte dysfunction and malnutrition, which are triggered by overaccumulation of triglycerides in the cytosol derived from mother’s milk (<xref ref-type="bibr" rid="b73">73</xref>, <xref ref-type="bibr" rid="b100">100</xref>). Liver-specific LPCAT3 deficiency leads to hepatic steatosis under a high-fat diet (<xref ref-type="bibr" rid="b100">100</xref>). These phenotypes do not match with those of known eicosanoid receptor- or eicosanoid synthetic enzyme-deficient mice, and basal eicosanoid levels are unchanged in tissues from LPCAT3-deficient mice (<xref ref-type="bibr" rid="b73">73</xref>). This suggests that AA-GPLs, and not eicosanoids, are important for triglyceride clearance from enterocytes and hepatocytes. Indeed, triglycerides surrounded by AA-GPLs are better transported by microsomal triglyceride transfer protein, which is critical for secretion of triglycerides and lipoprotein production (<xref ref-type="bibr" rid="b73">73</xref>). Therefore, the phenotypes of LPCAT3-deficient mice revealed previously unrecognized functions of PUFA-GPLs at the interface between the cytosol and triglycerides surrounded by endoplasmic reticulum leaflets. Further studies revealed that PUFA-PCs reduce the surface tension at the interface between water and triglycerides and affect the budding of lipid droplets in vitro (<xref ref-type="bibr" rid="b104">104</xref>). It will be interesting to investigate the relationship between this observation and the phenotypes of LPCAT3-deficiency. In addition to these triglyceride-related phenotypes, LPCAT3 deficiency in intestinal stem cells causes the overproduction of cholesterol, which further leads to cellular overproliferation (<xref ref-type="bibr" rid="b103">103</xref>). This overproliferation enhanced tumor formation in an Apc<sup>min</sup> genetic background (a mouse model of colon cancer). While the implication of sterol regulatory element-binding protein 2 was shown in this process, detailed molecular mechanisms connecting LPCAT3, AA-GPLs, and cholesterol regulation remain to be solved. A role of LPCAT3 in adipocyte differentiation was also reported (<xref ref-type="bibr" rid="b96">96</xref>). Using 3T3-L1 cells as a model, knockdown of LPCAT3 by shRNA decreased PUFA-GPLs (note that in contrast to other reports, DHA-GPLs also changed) and inhibited adipogenesis. The Wnt/β-catenin pathway was activated upon LPCAT3 knockdown, the inhibition of which restored adipogenesis. This makes a potential link between AA-GPLs and adipogenesis through Wnt/β-catenin. However, regulatory roles of eicosanoids in adipogenesis have also been documented (<xref ref-type="bibr" rid="b105">105</xref>), thus it remains to be established whether AA-GPLs regulate the process.</p>
<p>MBOAT7 deficiency leads to defects in neuronal migration and neurite outgrowth, leading to abnormal brain morphology in mice (<xref ref-type="bibr" rid="b76">76</xref>). Rare mutations in human MBOAT7 also cause neurodevelopmental defects (<xref ref-type="bibr" rid="b106">106</xref>). MBOAT7 deficiency decreases AA levels not only in PI but also in phosphoinositides (<xref ref-type="bibr" rid="b76">76</xref>). Quantitative changes in total levels of phosphoinositides are also reported (<xref ref-type="bibr" rid="b95">95</xref>). It is therefore possible that aberrant signaling by phosphoinositides is involved in the outcomes of MBOAT7 deficiency, but effector proteins that can discriminate phosphoinositide acyl-chains remain to be discovered. In line with this possibility, genetics studies in <italic>Caenorhabditis elegans</italic> suggest that PI acyl-chains affect PI 3-phosphate signaling (<xref ref-type="bibr" rid="b98">98</xref>). Genetic variants of MBOAT7 in humans are reported to affect nonalcoholic fatty liver disease, but inconsistencies are also suggested (<xref ref-type="bibr" rid="b107">107</xref>). In mice, liver-specific MBOAT7 knockdown or knockout promotes fatty liver (<xref ref-type="bibr" rid="b108">108</xref>, <xref ref-type="bibr" rid="b109">109</xref>). Triglyceride synthesis is promoted under MBOAT7 insufficiency, in part due to the higher turnover of PI (both synthesis and degradation are promoted) and the higher production of diacylglycerol thereof (see “PI cycle” in <xref ref-type="fig" rid="f1">Fig. 1</xref>) (<xref ref-type="bibr" rid="b110">110</xref>). It will be interesting to investigate whether phosphoinositides are also involved in the fatty liver phenotype.</p>
<p>The investigation of LPLATs also revealed how PUFA-GPLs affect the functions of membrane proteins. By combining PUFA feeding and genetic manipulation of LPLATs in <italic>Caenorhabditis elegans</italic>, it was found that PUFA-GPLs regulate proteins involved in touch sensation (<xref ref-type="bibr" rid="b110">110</xref>). In another study, researchers generated transgenic worms expressing human TRPV4 (transient receptor potential vanilloid 4) to study how PUFA-GPLs affect its function (<xref ref-type="bibr" rid="b111">111</xref>). Through a combination of PUFA feeding and manipulation of LPLATs in these worms, they demonstrated a regulatory role of PUFA-GPLs (more specifically, GPLs containing PUFA epoxides) in vasodilation. These studies demonstrate the usefulness of LPLATs as a tool to discriminate the functions of PUFAs as lipid mediators or as membrane components.</p>
</sec>
<sec>
<title>Future directions</title>
<p>Although it was difficult to discriminate whether PUFAs execute their functions through PUFA-derivatives or PUFA-GPLs, LPLAT research will probably help with this discrimination and make the functions of PUFA-GPLs clearer. It remains challenging to discover their precise molecular mechanisms, but many useful tools are being developed, such as proteome-wide identification of PUFA-interacting proteins (<xref ref-type="bibr" rid="b112">112</xref>), and genome-wide knockout screens (<xref ref-type="bibr" rid="b113">113</xref>). It is also important to visualize localization and movement of PUFA derivatives in the cells. Combination of these tools with the manipulation of PUFA-GPLs using LPLATs will be a promising approach to achieve a deep understanding of PUFA-GPL functions. Finally, the existence of PUFA level sensors is suggested in multiple studies (<xref ref-type="bibr" rid="b110">110</xref>, <xref ref-type="bibr" rid="b114">114</xref>), which will be important to identify. With all of these issues and others cleared, we will finally have a clear understanding about how PUFAs affect health and disease.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>The authors are grateful to all members of Takao Shimizu’s laboratory (University of Tokyo and National Center for Global Health and Medicine) and Howard Riezman’s laboratory (University of Geneva), and Professor George Carman at Rutgers University for valuable comments.</p>
</ack>
<fn-group>
<fn fn-type="abbr" id="gloss1">
<p>
<def-list>
<title>Abbreviations:</title>
<def-item>
<term>2-AG</term>
<def>
<p>2-arachidonoylglycerol</p>
</def>
</def-item>
<def-item>
<term>cPLA<sub>2</sub>α</term>
<def>
<p>cytosolic phospholipase A<sub>2</sub>α</p>
</def>
</def-item>
<def-item>
<term>GPCR</term>
<def>
<p>G protein-coupled receptor</p>
</def>
</def-item>
<def-item>
<term>GPL</term>
<def>
<p>glycerophospholipid</p>
</def>
</def-item>
<def-item>
<term>LA</term>
<def>
<p>linoleic acid</p>
</def>
</def-item>
<def-item>
<term>LPAAT</term>
<def>
<p>lysophosphatidic acid acyltransferase</p>
</def>
</def-item>
<def-item>
<term>LPLAT</term>
<def>
<p>lysophospholipid acyltransferase</p>
</def>
</def-item>
<def-item>
<term>PLA<sub>2</sub></term>
<def>
<p>phospholipase A<sub>2</sub></p>
</def>
</def-item>
<def-item>
<term>PLA2G2D</term>
<def>
<p>phospholipase A<sub>2</sub> group 2D</p>
</def>
</def-item>
</def-list>
</p>
</fn>
<fn fn-type="financial-disclosure">
<p>T.S. is supported by the <funding-source rid="sp1">Japan Agency for Medical Research and Development</funding-source> GAPFREE Program (2015–2020), the <funding-source rid="sp2">Takeda Science Foundation</funding-source> (2014, 2017), and was a recipient of a 50th Anniversary <italic>Journal of Lipid Research</italic> Lecture Award (2009). T.H. is supported by NCCR Chemical Biology and the <funding-source rid="sp3">Swiss National Science Foundation</funding-source> (grants attributed to Howard Riezman, University of Geneva), and the <funding-source rid="sp4">Japan Society for the Promotion of Science</funding-source> Postdoctoral Fellowships for Research Abroad. The Department of Lipidomics at the University of Tokyo is funded by Shimadzu Company, Ltd., and the Lipid Signaling Project of the National Center for Global Health and Medicine is supported by Ono Pharmaceutical Company. <named-content content-type="COI-statement">The authors declare that they have no conflicts of interest with the contents of this article.</named-content></p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="b1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fulco</surname><given-names>A. J.</given-names></name>, and <name name-style="western"><surname>Mead</surname><given-names>J. F.</given-names></name></person-group>
<year>1959</year>
<article-title>Metabolism of essential fatty acids. VIII. Origin of 5,8,11-eicosatrienoic acid in the fat-deficient rat</article-title>. <source/>J. Biol. Chem.
<volume>234</volume>: <fpage>1411</fpage>–<lpage>1416</lpage>.<pub-id pub-id-type="pmid">13654388</pub-id></mixed-citation>
</ref>
<ref id="b2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guillou</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Zadravec</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>P. G. P.</given-names></name>, and <name name-style="western"><surname>Jacobsson</surname><given-names>A.</given-names></name></person-group>
<year>2010</year>
<article-title>The key roles of elongases and desaturases in mammalian fatty acid metabolism: insights from transgenic mice</article-title>. <source/>Prog. Lipid Res.
<volume>49</volume>: <fpage>186</fpage>–<lpage>199</lpage>.<pub-id pub-id-type="pmid">20018209</pub-id></mixed-citation>
</ref>
<ref id="b3">
<label>3.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>H. M.</given-names></name>, <name name-style="western"><surname>Moser</surname><given-names>A. B.</given-names></name>, <name name-style="western"><surname>Moser</surname><given-names>H. W.</given-names></name>, and <name name-style="western"><surname>Watkins</surname><given-names>P. A.</given-names></name></person-group>
<year>2001</year>
<article-title>Peroxisomal straight-chain acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis</article-title>. <source/>J. Biol. Chem.
<volume>276</volume>: <fpage>38115</fpage>–<lpage>38120</lpage>.<pub-id pub-id-type="pmid">11500517</pub-id></mixed-citation>
</ref>
<ref id="b4">
<label>4.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>Y-Y.</given-names></name>, <name name-style="western"><surname>Monk</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>T. Y.</given-names></name>, <name name-style="western"><surname>Callway</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Vincent</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Weeks</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>P.</given-names></name>, and <name name-style="western"><surname>Chapkin</surname><given-names>R. S.</given-names></name></person-group>
<year>2012</year>
<article-title>Characterization of an arachidonic acid-deficient (<italic>Fads1</italic> knockout) mouse model</article-title>. <source/>J. Lipid Res.
<volume>53</volume>: <fpage>1287</fpage>–<lpage>1295</lpage>.<pub-id pub-id-type="pmid">22534642</pub-id></mixed-citation>
</ref>
<ref id="b5">
<label>5.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harauma</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hatanaka</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Yasuda</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>M. T.</given-names></name>, <name name-style="western"><surname>Salem</surname><given-names>N.</given-names></name>, and <name name-style="western"><surname>Moriguchi</surname><given-names>T.</given-names></name></person-group>
<year>2017</year>
<article-title>Effects of arachidonic acid, eicosapentaenoic acid and docosahexaenoic acid on brain development using artificial rearing of delta-6-desaturase knockout mice</article-title>. <source/>Prostaglandins Leukot. Essent. Fatty Acids.
<volume>127</volume>: <fpage>32</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">29156156</pub-id></mixed-citation>
</ref>
<ref id="b6">
<label>6.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moon</surname><given-names>Y-A.</given-names></name>, <name name-style="western"><surname>Hammer</surname><given-names>R. E.</given-names></name>, and <name name-style="western"><surname>Horton</surname><given-names>J. D.</given-names></name></person-group>
<year>2009</year>
<article-title>Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice</article-title>. <source/>J. Lipid Res.
<volume>50</volume>: <fpage>412</fpage>–<lpage>423</lpage>.<pub-id pub-id-type="pmid">18838740</pub-id></mixed-citation>
</ref>
<ref id="b7">
<label>7.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pauter</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Olsson</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Asadi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Herslöf</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Csikasz</surname><given-names>R. I.</given-names></name>, <name name-style="western"><surname>Zadravec</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Jacobsson</surname><given-names>A.</given-names></name></person-group>
<year>2014</year>
<article-title>Elovl2 ablation demonstrates that systemic DHA is endogenously produced and is essential for lipid homeostasis in mice</article-title>. <source/>J. Lipid Res.
<volume>55</volume>: <fpage>718</fpage>–<lpage>728</lpage>.<pub-id pub-id-type="pmid">24489111</pub-id></mixed-citation>
</ref>
<ref id="b8">
<label>8.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roqueta-Rivera</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Stroud</surname><given-names>C. K.</given-names></name>, <name name-style="western"><surname>Haschek</surname><given-names>W. M.</given-names></name>, <name name-style="western"><surname>Akare</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Segre</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Brush</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Agbaga</surname><given-names>M-P.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>R. E.</given-names></name>, <name name-style="western"><surname>Hess</surname><given-names>R. A.</given-names></name>, and <name name-style="western"><surname>Nakamura</surname><given-names>M. T.</given-names></name></person-group>
<year>2010</year>
<article-title>Docosahexaenoic acid supplementation fully restores fertility and spermatogenesis in male delta-6 desaturase-null mice</article-title>. <source/>J. Lipid Res.
<volume>51</volume>: <fpage>360</fpage>–<lpage>367</lpage>.<pub-id pub-id-type="pmid">19690334</pub-id></mixed-citation>
</ref>
<ref id="b9">
<label>9.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoffel</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Hammels</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Jenke</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Binczek</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Schmidt-Soltau</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Brodesser</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Odenthal</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Thevis</surname><given-names>M.</given-names></name></person-group>
<year>2014</year>
<article-title>Obesity resistance and deregulation of lipogenesis in Δ6-fatty acid desaturase (FADS2) deficiency</article-title>. <source/>EMBO Rep.
<volume>15</volume>: <fpage>110</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">24378641</pub-id></mixed-citation>
</ref>
<ref id="b10">
<label>10.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoffel</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Holz</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Jenke</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Binczek</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Günter</surname><given-names>R. H.</given-names></name>, <name name-style="western"><surname>Kiss</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Karakesisoglou</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Thevis</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>A-A.</given-names></name>, <name name-style="western"><surname>Arnhold</surname><given-names>S.</given-names></name>, <etal></etal></person-group>
<year>2008</year>
<article-title>Δ6-Desaturase (FADS2) deficiency unveils the role of ω3- and ω6-polyunsaturated fatty acids</article-title>. <source/>EMBO J.
<volume>27</volume>: <fpage>2281</fpage>–<lpage>2292</lpage>.<pub-id pub-id-type="pmid">19172737</pub-id></mixed-citation>
</ref>
<ref id="b11">
<label>11.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stroud</surname><given-names>C. K.</given-names></name>, <name name-style="western"><surname>Nara</surname><given-names>T. Y.</given-names></name>, <name name-style="western"><surname>Roqueta-Rivera</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Radlowski</surname><given-names>E. C.</given-names></name>, <name name-style="western"><surname>Lawrence</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>B. H.</given-names></name>, <name name-style="western"><surname>Segre</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hess</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Brenna</surname><given-names>J. T.</given-names></name>, <etal></etal></person-group>
<year>2009</year>
<article-title>Disruption of FADS2 gene in mice impairs male reproduction and causes dermal and intestinal ulceration</article-title>. <source/>J. Lipid Res.
<volume>50</volume>: <fpage>1870</fpage>–<lpage>1880</lpage>.<pub-id pub-id-type="pmid">19351970</pub-id></mixed-citation>
</ref>
<ref id="b12">
<label>12.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Talamonti</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Pauter</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Asadi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fischer</surname><given-names>A. W.</given-names></name>, <name name-style="western"><surname>Chiurchiù</surname><given-names>V.</given-names></name>, and <name name-style="western"><surname>Jacobsson</surname><given-names>A.</given-names></name></person-group>
<year>2017</year>
<article-title>Impairment of systemic DHA synthesis affects macrophage plasticity and polarization: implications for DHA supplementation during inflammation</article-title>. <source/>Cell. Mol. Life Sci.
<volume>74</volume>: <fpage>2815</fpage>–<lpage>2826</lpage>.<pub-id pub-id-type="pmid">28299384</pub-id></mixed-citation>
</ref>
<ref id="b13">
<label>13.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zadravec</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Tvrdik</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Guillou</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Haslam</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Napier</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Capecchi</surname><given-names>M. R.</given-names></name>, and <name name-style="western"><surname>Jacobsson</surname><given-names>A.</given-names></name></person-group>
<year>2011</year>
<article-title>ELOVL2 controls the level of n-6 28:5 and 30:5 fatty acids in testis, a prerequisite for male fertility and sperm maturation in mice</article-title>. <source/>J. Lipid Res.
<volume>52</volume>: <fpage>245</fpage>–<lpage>255</lpage>.<pub-id pub-id-type="pmid">21106902</pub-id></mixed-citation>
</ref>
<ref id="b14">
<label>14.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Powell</surname><given-names>D. R.</given-names></name>, <name name-style="western"><surname>Gay</surname><given-names>J. P.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wilganowski</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Harris</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Holland</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Reyes</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kirkham</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kirkpatrick</surname><given-names>L. L.</given-names></name>, <name name-style="western"><surname>Zambrowicz</surname><given-names>B.</given-names></name>, <etal></etal></person-group>
<year>2016</year>
<article-title>Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque</article-title>. <source/>Diabetes Metab. Syndr. Obes.
<volume>9</volume>: <fpage>185</fpage>–<lpage>199</lpage>.<pub-id pub-id-type="pmid">27382320</pub-id></mixed-citation>
</ref>
<ref id="b15">
<label>15.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levental</surname><given-names>K. R.</given-names></name>, <name name-style="western"><surname>Surma</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Skinkle</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Lorent</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Klose</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>J. T.</given-names></name>, <name name-style="western"><surname>Hancock</surname><given-names>J. F.</given-names></name>, and <name name-style="western"><surname>Levental</surname><given-names>I.</given-names></name></person-group>
<year>2017</year>
<article-title>ω-3 Polyunsaturated fatty acids direct differentiation of the membrane phenotype in mesenchymal stem cells to potentiate osteogenesis</article-title>. <source/>Sci. Adv.
<volume>3</volume>: <fpage>eaao1193</fpage>.<pub-id pub-id-type="pmid">29134198</pub-id></mixed-citation>
</ref>
<ref id="b16">
<label>16.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romero</surname><given-names>L. O.</given-names></name>, <name name-style="western"><surname>Massey</surname><given-names>A. E.</given-names></name>, <name name-style="western"><surname>Mata-Daboin</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Sierra-Valdez</surname><given-names>F. J.</given-names></name>, <name name-style="western"><surname>Chauhan</surname><given-names>S. C.</given-names></name>, <name name-style="western"><surname>Cordero-Morales</surname><given-names>J. F.</given-names></name>, and <name name-style="western"><surname>Vásquez</surname><given-names>V.</given-names></name></person-group>
<year>2019</year>
<article-title>Dietary fatty acids fine-tune Piezo1 mechanical response</article-title>. <source/>Nat. Commun.
<volume>10</volume>: <fpage>1200</fpage>.<pub-id pub-id-type="pmid">30867417</pub-id></mixed-citation>
</ref>
<ref id="b17">
<label>17.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name></person-group>
<year>2009</year>
<article-title>Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation</article-title>. <source/>Annu. Rev. Pharmacol. Toxicol.
<volume>49</volume>: <fpage>123</fpage>–<lpage>150</lpage>.<pub-id pub-id-type="pmid">18834304</pub-id></mixed-citation>
</ref>
<ref id="b18">
<label>18.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>R. C.</given-names></name>, and <name name-style="western"><surname>Folco</surname><given-names>G.</given-names></name></person-group>
<year>2019</year>
<article-title>Lysophospholipid acyltransferases and leukotriene biosynthesis: intersection of the Lands cycle and the arachidonate PI cycle</article-title>. <source/>J. Lipid Res.
<volume>60</volume>: <fpage>219</fpage>–<lpage>226</lpage>.<pub-id pub-id-type="pmid">30606731</pub-id></mixed-citation>
</ref>
<ref id="b19">
<label>19.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirano</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>Y-G.</given-names></name>, <name name-style="western"><surname>Stephenson</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Vu</surname><given-names>N. T.</given-names></name>, <name name-style="western"><surname>Malinina</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Simanshu</surname><given-names>D. K.</given-names></name>, <name name-style="western"><surname>Chalfant</surname><given-names>C. E.</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>D. J.</given-names></name>, and <name name-style="western"><surname>Brown</surname><given-names>R. E.</given-names></name></person-group>
<year>2019</year>
<article-title>Structural basis of phosphatidylcholine recognition by the C2-domain of cytosolic phospholipase A<sub>2</sub>α</article-title>. <source/>eLife.
<volume>8</volume>: <fpage>e44760</fpage>.<pub-id pub-id-type="pmid">31050338</pub-id></mixed-citation>
</ref>
<ref id="b20">
<label>20.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Burke</surname><given-names>J. E.</given-names></name>, and <name name-style="western"><surname>Dennis</surname><given-names>E. A.</given-names></name></person-group>
<year>2013</year>
<article-title>Using hydrogen/deuterium exchange mass spectrometry to define the specific interactions of the phospholipase A<sub>2</sub> superfamily with lipid substrates, inhibitors, and membranes</article-title>. <source/>J. Biol. Chem.
<volume>288</volume>: <fpage>1806</fpage>–<lpage>1813</lpage>.<pub-id pub-id-type="pmid">23209293</pub-id></mixed-citation>
</ref>
<ref id="b21">
<label>21.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mouchlis</surname><given-names>V. D.</given-names></name>, <name name-style="western"><surname>Bucher</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>McCammon</surname><given-names>J. A.</given-names></name>, and <name name-style="western"><surname>Dennis</surname><given-names>E. A.</given-names></name></person-group>
<year>2015</year>
<article-title>Membranes serve as allosteric activators of phospholipase A<sub>2</sub>, enabling it to extract, bind, and hydrolyze phospholipid substrates</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>112</volume>: <fpage>E516</fpage>–<lpage>E525</lpage>.<pub-id pub-id-type="pmid">25624474</pub-id></mixed-citation>
</ref>
<ref id="b22">
<label>22.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arensdorf</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Dillard</surname><given-names>M. E.</given-names></name>, <name name-style="western"><surname>Menke</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Frank</surname><given-names>M. W.</given-names></name>, <name name-style="western"><surname>Rock</surname><given-names>C. O.</given-names></name>, and <name name-style="western"><surname>Ogden</surname><given-names>S. K.</given-names></name></person-group>
<year>2017</year>
<article-title>Sonic hedgehog activates phospholipase A<sub>2</sub> to enhance smoothened ciliary translocation</article-title>. <source/>Cell Rep.
<volume>19</volume>: <fpage>2074</fpage>–<lpage>2087</lpage>.<pub-id pub-id-type="pmid">28591579</pub-id></mixed-citation>
</ref>
<ref id="b23">
<label>23.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le</surname><given-names>T. D.</given-names></name>, <name name-style="western"><surname>Shirai</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Okamoto</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Tatsukawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Nagao</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Ito</surname><given-names>M.</given-names></name></person-group>
<year>2010</year>
<article-title>Lipid signaling in cytosolic phospholipase A<sub>2</sub>α-cyclooxygenase-2 cascade mediates cerebellar long-term depression and motor learning</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>107</volume>: <fpage>3198</fpage>–<lpage>3203</lpage>.<pub-id pub-id-type="pmid">20133605</pub-id></mixed-citation>
</ref>
<ref id="b24">
<label>24.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uozumi</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Kume</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Nagase</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Nakatani</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ishii</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Tashiro</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Komagata</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Maki</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ikuta</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ouchi</surname><given-names>Y.</given-names></name>, <etal></etal></person-group>
<year>1997</year>
<article-title>Role of cytosolic phospholipase A<sub>2</sub> in allergic response and parturition</article-title>. <source/>Nature.
<volume>390</volume>: <fpage>618</fpage>–<lpage>622</lpage>.<pub-id pub-id-type="pmid">9403692</pub-id></mixed-citation>
</ref>
<ref id="b25">
<label>25.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murakami</surname><given-names>M.</given-names></name></person-group>
<year>2017</year>
<article-title>Lipoquality control by phospholipase A<sub>2</sub> enzymes</article-title>. <source/>Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci.
<volume>93</volume>: <fpage>677</fpage>–<lpage>702</lpage>.</mixed-citation>
</ref>
<ref id="b26">
<label>26.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dichlberger</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Schlager</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Maaninka</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>W. J.</given-names></name>, and <name name-style="western"><surname>Kovanen</surname><given-names>P. T.</given-names></name></person-group>
<year>2014</year>
<article-title>Adipose triglyceride lipase regulates eicosanoid production in activated human mast cells</article-title>. <source/>J. Lipid Res.
<volume>55</volume>: <fpage>2471</fpage>–<lpage>2478</lpage>.<pub-id pub-id-type="pmid">25114172</pub-id></mixed-citation>
</ref>
<ref id="b27">
<label>27.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nomura</surname><given-names>D. K.</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>B. E.</given-names></name>, <name name-style="western"><surname>Blankman</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Long</surname><given-names>J. Z.</given-names></name>, <name name-style="western"><surname>Kinsey</surname><given-names>S. G.</given-names></name>, <name name-style="western"><surname>Marcondes</surname><given-names>M. C. G.</given-names></name>, <name name-style="western"><surname>Ward</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Hahn</surname><given-names>Y. K.</given-names></name>, <name name-style="western"><surname>Lichtman</surname><given-names>A. H.</given-names></name>, <name name-style="western"><surname>Conti</surname><given-names>B.</given-names></name>, <etal></etal></person-group>
<year>2011</year>
<article-title>Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation</article-title>. <source/>Science.
<volume>334</volume>: <fpage>809</fpage>–<lpage>813</lpage>.<pub-id pub-id-type="pmid">22021672</pub-id></mixed-citation>
</ref>
<ref id="b28">
<label>28.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kita</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Tokuoka</surname><given-names>S. M.</given-names></name>, <name name-style="western"><surname>Hamano</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Yamazaki</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sakimura</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kano</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name></person-group>
<year>2015</year>
<article-title>Fever is mediated by conversion of endocannabinoid 2-arachidonoylglycerol to prostaglandin E<sub>2</sub></article-title>. <source/>PLoS One.
<volume>10</volume>: <fpage>e0133663</fpage>.<pub-id pub-id-type="pmid">26196692</pub-id></mixed-citation>
</ref>
<ref id="b29">
<label>29.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piro</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Benjamin</surname><given-names>D. I.</given-names></name>, <name name-style="western"><surname>Duerr</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Pi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Gonzales</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Schwartz</surname><given-names>J. W.</given-names></name>, <name name-style="western"><surname>Nomura</surname><given-names>D. K.</given-names></name>, and <name name-style="western"><surname>Samad</surname><given-names>T. A.</given-names></name></person-group>
<year>2012</year>
<article-title>A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer’s disease</article-title>. <source/>Cell Rep.
<volume>1</volume>: <fpage>617</fpage>–<lpage>623</lpage>.<pub-id pub-id-type="pmid">22813736</pub-id></mixed-citation>
</ref>
<ref id="b30">
<label>30.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Mulvihill</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Mukhopadhyay</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Erdélyi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hao</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Holovac</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Haskó</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Cravatt</surname><given-names>B. F.</given-names></name>, <name name-style="western"><surname>Nomura</surname><given-names>D. K.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice</article-title>. <source/>Gastroenterology.
<volume>144</volume>: <fpage>808</fpage>–<lpage>817.e15</lpage>.<pub-id pub-id-type="pmid">23295443</pub-id></mixed-citation>
</ref>
<ref id="b31">
<label>31.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dalli</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Serhan</surname><given-names>C. N.</given-names></name></person-group>
<year>2019</year>
<article-title>Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology</article-title>. <source/>Br. J. Pharmacol.
<volume>176</volume>: <fpage>1024</fpage>–<lpage>1037</lpage>.<pub-id pub-id-type="pmid">29679485</pub-id></mixed-citation>
</ref>
<ref id="b32">
<label>32.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Serhan</surname><given-names>C. N.</given-names></name></person-group>
<year>2014</year>
<article-title>Pro-resolving lipid mediators are leads for resolution physiology</article-title>. <source/>Nature.
<volume>510</volume>: <fpage>92</fpage>–<lpage>101</lpage>.<pub-id pub-id-type="pmid">24899309</pub-id></mixed-citation>
</ref>
<ref id="b33">
<label>33.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shimanaka</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kono</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Taketomi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Arita</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Okayama</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Nishito</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Mochizuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kusuhara</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Adibekian</surname><given-names>A.</given-names></name>, <etal></etal></person-group>
<year>2017</year>
<article-title>Omega-3 fatty acid epoxides are autocrine mediators that control the magnitude of IgE-mediated mast cell activation</article-title>. <source/>Nat. Med.
<volume>23</volume>: <fpage>1287</fpage>–<lpage>1297</lpage>.<pub-id pub-id-type="pmid">29035365</pub-id></mixed-citation>
</ref>
<ref id="b34">
<label>34.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miki</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Taketomi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Shimo</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ishikawa</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ishii</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Nakanishi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ikeda</surname><given-names>K.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>Lymphoid tissue phospholipase A<sub>2</sub> group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators</article-title>. <source/>J. Exp. Med.
<volume>210</volume>: <fpage>1217</fpage>–<lpage>1234</lpage>.<pub-id pub-id-type="pmid">23690440</pub-id></mixed-citation>
</ref>
<ref id="b35">
<label>35.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Taketomi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Miki</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Murase</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>K.</given-names></name>, and <name name-style="western"><surname>Murakami</surname><given-names>M.</given-names></name></person-group>
<year>2020</year>
<article-title>Secreted phospholipase PLA2G2D contributes to metabolic health by mobilizing ω3 polyunsaturated fatty acids in WAT</article-title>. <source/>Cell Rep.
<volume>31</volume>: <fpage>107579</fpage>.<pub-id pub-id-type="pmid">32375030</pub-id></mixed-citation>
</ref>
<ref id="b36">
<label>36.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hilgendorf</surname><given-names>K. I.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>C. T.</given-names></name>, <name name-style="western"><surname>Mezger</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Rice</surname><given-names>S. L.</given-names></name>, <name name-style="western"><surname>Norris</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Demeter</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Greenleaf</surname><given-names>W. J.</given-names></name>, <name name-style="western"><surname>Reiter</surname><given-names>J. F.</given-names></name>, <name name-style="western"><surname>Kopinke</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Jackson</surname><given-names>P. K.</given-names></name></person-group>
<year>2019</year>
<article-title>Omega-3 fatty acids activate ciliary FFAR4 to control adipogenesis</article-title>. <source/>Cell.
<volume>179</volume>: <fpage>1289</fpage>–<lpage>1305.e21</lpage>.<pub-id pub-id-type="pmid">31761534</pub-id></mixed-citation>
</ref>
<ref id="b37">
<label>37.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oh</surname><given-names>D. Y.</given-names></name>, <name name-style="western"><surname>Talukdar</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bae</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Imamura</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Morinaga</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>W. J.</given-names></name>, <name name-style="western"><surname>Watkins</surname><given-names>S. M.</given-names></name>, and <name name-style="western"><surname>Olefsky</surname><given-names>J. M.</given-names></name></person-group>
<year>2010</year>
<article-title>GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects</article-title>. <source/>Cell.
<volume>142</volume>: <fpage>687</fpage>–<lpage>698</lpage>.<pub-id pub-id-type="pmid">20813258</pub-id></mixed-citation>
</ref>
<ref id="b38">
<label>38.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donvito</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Nass</surname><given-names>S. R.</given-names></name>, <name name-style="western"><surname>Wilkerson</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Curry</surname><given-names>Z. A.</given-names></name>, <name name-style="western"><surname>Schurman</surname><given-names>L. D.</given-names></name>, <name name-style="western"><surname>Kinsey</surname><given-names>S. G.</given-names></name>, and <name name-style="western"><surname>Lichtman</surname><given-names>A. H.</given-names></name></person-group>
<year>2018</year>
<article-title>The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain</article-title>. <source/>Neuropsychopharmacology.
<volume>43</volume>: <fpage>52</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">28857069</pub-id></mixed-citation>
</ref>
<ref id="b39">
<label>39.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanimura</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yamazaki</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hashimotodani</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Uchigashima</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kawata</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Abe</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kita</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Hashimoto</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>M.</given-names></name>, <etal></etal></person-group>
<year>2010</year>
<article-title>The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase α mediates retrograde suppression of synaptic transmission</article-title>. <source/>Neuron.
<volume>65</volume>: <fpage>320</fpage>–<lpage>327</lpage>.<pub-id pub-id-type="pmid">20159446</pub-id></mixed-citation>
</ref>
<ref id="b40">
<label>40.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamashita</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kumazawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Koga</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Oka</surname><given-names>S.</given-names></name>, and <name name-style="western"><surname>Sugiura</surname><given-names>T.</given-names></name></person-group>
<year>2010</year>
<article-title>Generation of lysophosphatidylinositol by DDHD domain containing 1 (DDHD1): possible involvement of phospholipase D/phosphatidic acid in the activation of DDHD1</article-title>. <source/>Biochim. Biophys. Acta.
<volume>1801</volume>: <fpage>711</fpage>–<lpage>720</lpage>.<pub-id pub-id-type="pmid">20359546</pub-id></mixed-citation>
</ref>
<ref id="b41">
<label>41.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sumida</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Mackie</surname><given-names>K.</given-names></name>, and <name name-style="western"><surname>Cyster</surname><given-names>J. G.</given-names></name></person-group>
<year>2017</year>
<article-title>GPR55 regulates intraepithelial lymphocyte migration dynamics and susceptibility to intestinal damage</article-title>. <source/>J. Sci. Immunol.
<volume>2</volume>: <fpage>eaao1135</fpage>.</mixed-citation>
</ref>
<ref id="b42">
<label>42.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giménez-Bastida</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Shibata</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Uchida</surname><given-names>K.</given-names></name>, and <name name-style="western"><surname>Schneider</surname><given-names>C.</given-names></name></person-group>
<year>2017</year>
<article-title>Roles of 5-lipoxygenase and cyclooxygenase-2 in the biosynthesis of hemiketals E2 and D2 by activated human leukocytes</article-title>. <source/>FASEB J.
<volume>31</volume>: <fpage>1867</fpage>–<lpage>1878</lpage>.<pub-id pub-id-type="pmid">28096231</pub-id></mixed-citation>
</ref>
<ref id="b43">
<label>43.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuda</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Brezinova</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Rombaldova</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Slavikova</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Posta</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Beier</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Janovska</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Veleba</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kopecky</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kudova</surname><given-names>E.</given-names></name>, <etal></etal></person-group>
<year>2016</year>
<article-title>Docosahexaenoic acid-derived fatty acid esters of hydroxy fatty acids (FAHFAs) with anti-inflammatory properties</article-title>. <source/>Diabetes.
<volume>65</volume>: <fpage>2580</fpage>–<lpage>2590</lpage>.<pub-id pub-id-type="pmid">27313314</pub-id></mixed-citation>
</ref>
<ref id="b44">
<label>44.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Southern</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Cook</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Neetoo-Isseljee</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>D. L.</given-names></name>, <name name-style="western"><surname>Kettleborough</surname><given-names>C. A.</given-names></name>, <name name-style="western"><surname>Merritt</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bassoni</surname><given-names>D. L.</given-names></name>, <name name-style="western"><surname>Raab</surname><given-names>W. J.</given-names></name>, <name name-style="western"><surname>Quinn</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Wehrman</surname><given-names>T. S.</given-names></name>, <etal></etal></person-group>
<year>2013</year>
<article-title>Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein–coupled receptors</article-title>. <source/>J. Biomol. Screen.
<volume>18</volume>: <fpage>599</fpage>–<lpage>609</lpage>.<pub-id pub-id-type="pmid">23396314</pub-id></mixed-citation>
</ref>
<ref id="b45">
<label>45.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McHugh</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>S. S. J.</given-names></name>, <name name-style="western"><surname>Rimmerman</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Juknat</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Vogel</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>J. M.</given-names></name>, and <name name-style="western"><surname>Bradshaw</surname><given-names>H. B.</given-names></name></person-group>
<year>2010</year>
<article-title>N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor</article-title>. <source/>BMC Neurosci.
<volume>11</volume>: <fpage>44</fpage>.<pub-id pub-id-type="pmid">20346144</pub-id></mixed-citation>
</ref>
<ref id="b46">
<label>46.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirata</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Narumiya</surname><given-names>S.</given-names></name></person-group>
<year>2011</year>
<article-title>Prostanoid Receptors</article-title>. <source/>Chem. Rev.
<volume>111</volume>: <fpage>6209</fpage>–<lpage>6230</lpage>.<pub-id pub-id-type="pmid">21819041</pub-id></mixed-citation>
</ref>
<ref id="b47">
<label>47.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murakami</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Yokomizo</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Okuno</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name></person-group>
<year>2004</year>
<article-title>G2A Is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>: <fpage>42484</fpage>–<lpage>42491</lpage>.<pub-id pub-id-type="pmid">15280385</pub-id></mixed-citation>
</ref>
<ref id="b48">
<label>48.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obinata</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hattori</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Nakane</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Tatei</surname><given-names>K.</given-names></name>, and <name name-style="western"><surname>Izumi</surname><given-names>T.</given-names></name></person-group>
<year>2005</year>
<article-title>Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A</article-title>. <source/>J. Biol. Chem.
<volume>280</volume>: <fpage>40676</fpage>–<lpage>40683</lpage>.<pub-id pub-id-type="pmid">16236715</pub-id></mixed-citation>
</ref>
<ref id="b49">
<label>49.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kennedy</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Davenport</surname><given-names>A. P.</given-names></name>, and <name name-style="western"><surname>Ohlstein</surname><given-names>E. H.</given-names></name></person-group>
<year>2018</year>
<article-title>International Union of Basic and Clinical Pharmacology CIII: Chemerin receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) nomenclature, pharmacology, and function</article-title>. <source/>Pharmacol. Rev.
<volume>70</volume>: <fpage>174</fpage>–<lpage>196</lpage>.<pub-id pub-id-type="pmid">29279348</pub-id></mixed-citation>
</ref>
<ref id="b50">
<label>50.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>Y-K.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z-J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Z-Z.</given-names></name>, and <name name-style="western"><surname>Ji</surname><given-names>R-R.</given-names></name></person-group>
<year>2018</year>
<article-title>GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain</article-title>. <source/>J. Clin. Invest.
<volume>128</volume>: <fpage>3568</fpage>–<lpage>3582</lpage>.<pub-id pub-id-type="pmid">30010619</pub-id></mixed-citation>
</ref>
<ref id="b51">
<label>51.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyer</surname><given-names>R. C.</given-names></name>, <name name-style="western"><surname>Giddens</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Schaefer</surname><given-names>S. A.</given-names></name>, and <name name-style="western"><surname>Hall</surname><given-names>R. A.</given-names></name></person-group>
<year>2013</year>
<article-title>GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin</article-title>. <source/>Proc. Natl. Acad. Sci. USA.
<volume>110</volume>: <fpage>9529</fpage>–<lpage>9534</lpage>.<pub-id pub-id-type="pmid">23690594</pub-id></mixed-citation>
</ref>
<ref id="b52">
<label>52.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakanishi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Montrose</surname><given-names>D. C.</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Nambiar</surname><given-names>P. R.</given-names></name>, <name name-style="western"><surname>Belinsky</surname><given-names>G. S.</given-names></name>, <name name-style="western"><surname>Claffey</surname><given-names>K. P.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Rosenberg</surname><given-names>D. W.</given-names></name></person-group>
<year>2008</year>
<article-title>Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis</article-title>. <source/>Cancer Res.
<volume>68</volume>: <fpage>3251</fpage>–<lpage>3259</lpage>.<pub-id pub-id-type="pmid">18451151</pub-id></mixed-citation>
</ref>
<ref id="b53">
<label>53.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sasaki</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kamei</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Ishikawa</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ishii</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Uematsu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Akira</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Murakami</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Hara</surname><given-names>S.</given-names></name></person-group>
<year>2012</year>
<article-title>Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis</article-title>. <source/>Oncogene.
<volume>31</volume>: <fpage>2943</fpage>–<lpage>2952</lpage>.<pub-id pub-id-type="pmid">21986945</pub-id></mixed-citation>
</ref>
<ref id="b54">
<label>54.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>H-B.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>Y-S.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>S-Y.</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>C. J.</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>J-H.</given-names></name>, <name name-style="western"><surname>Markowitz</surname><given-names>S. D.</given-names></name>, <etal></etal></person-group>
<year>2017</year>
<article-title>Prostaglandin E<sub>2</sub> activates YAP and a positive-signaling loop to promote colon regeneration after colitis but also carcinogenesis in mice</article-title>. <source/>Gastroenterology.
<volume>152</volume>: <fpage>616</fpage>–<lpage>630</lpage>.<pub-id pub-id-type="pmid">27864128</pub-id></mixed-citation>
</ref>
<ref id="b55">
<label>55.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roulis</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kaklamanos</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Schernthanner</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bielecki</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kaffe</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Frommelt</surname><given-names>L-S.</given-names></name>, <name name-style="western"><surname>Qu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Knapp</surname><given-names>M. S.</given-names></name>, <name name-style="western"><surname>Henriques</surname><given-names>A.</given-names></name>, <etal></etal></person-group>
<year>2020</year>
<article-title>Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche</article-title>. <source/>Nature.
<volume>580</volume>: <fpage>524</fpage>–<lpage>529</lpage>.<pub-id pub-id-type="pmid">32322056</pub-id></mixed-citation>
</ref>
<ref id="b56">
<label>56.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hori</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Okuno</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yamashita</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kawano</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hato</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yokomizo</surname><given-names>T.</given-names></name>, <etal></etal></person-group>
<year>2018</year>
<article-title>Na<sup>+</sup>-mimicking ligands stabilize the inactive state of leukotriene B<sub>4</sub> receptor BLT1</article-title>. <source/>Nat. Chem. Biol.
<volume>14</volume>: <fpage>262</fpage>–<lpage>269</lpage>.<pub-id pub-id-type="pmid">29309055</pub-id></mixed-citation>
</ref>
<ref id="b57">
<label>57.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Yao</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Deepak</surname><given-names>R. N. V. K.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Fan</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Gong</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>Z.</given-names></name>, and <name name-style="western"><surname>Zhang</surname><given-names>C.</given-names></name></person-group>
<year>2018</year>
<article-title>Structures of the human PGD<sub>2</sub> receptor CRTH2 reveal novel mechanisms for ligand recognition</article-title>. <source/>Mol. Cell.
<volume>72</volume>: <fpage>48</fpage>–<lpage>59.e4</lpage>.<pub-id pub-id-type="pmid">30220562</pub-id></mixed-citation>
</ref>
<ref id="b58">
<label>58.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morimoto</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Suno</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hotta</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yamashita</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Narumiya</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Iwata</surname><given-names>S.</given-names></name>, and <name name-style="western"><surname>Kobayashi</surname><given-names>T.</given-names></name></person-group>
<year>2019</year>
<article-title>Crystal structure of the endogenous agonist-bound prostanoid receptor EP3</article-title>. <source/>Nat. Chem. Biol.
<volume>15</volume>: <fpage>8</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">30510192</pub-id></mixed-citation>
</ref>
<ref id="b59">
<label>59.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hua</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Vemuri</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Nikas</surname><given-names>S. P.</given-names></name>, <name name-style="western"><surname>Laprairie</surname><given-names>R. B.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Qu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Pu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Korde</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>J-H.</given-names></name>, <etal></etal></person-group>
<year>2017</year>
<article-title>Crystal structures of agonist-bound human cannabinoid receptor CB1</article-title>. <source/>Nature.
<volume>547</volume>: <fpage>468</fpage>–<lpage>471</lpage>.<pub-id pub-id-type="pmid">28678776</pub-id></mixed-citation>
</ref>
<ref id="b60">
<label>60.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toyoda</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Morimoto</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Suno</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Horita</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yamashita</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Sekiguchi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yasuda</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Shiroishi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name>, <etal></etal></person-group>
<year>2019</year>
<article-title>Ligand binding to human prostaglandin E receptor EP<sub>4</sub> at the lipid-bilayer interface</article-title>. <source/>Nat. Chem. Biol.
<volume>15</volume>: <fpage>18</fpage>–<lpage>26</lpage>.<pub-id pub-id-type="pmid">30510193</pub-id></mixed-citation>
</ref>
<ref id="b61">
<label>61.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hua</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Vemuri</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Pu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Qu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>G. W.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Shui</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Korde</surname><given-names>A.</given-names></name>, <etal></etal></person-group>
<year>2016</year>
<article-title>Crystal structure of the human cannabinoid receptor CB1</article-title>. <source/>Cell.
<volume>167</volume>: <fpage>750</fpage>–<lpage>762.e14</lpage>.<pub-id pub-id-type="pmid">27768894</pub-id></mixed-citation>
</ref>
<ref id="b62">
<label>62.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Krishna Kumar</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Shalev-Benami</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Robertson</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Banister</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Hollingsworth</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Latorraca</surname><given-names>N. R.</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>H. E.</given-names></name>, <name name-style="western"><surname>Hilger</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Maeda</surname><given-names>S.</given-names></name>, <etal></etal></person-group>
<year>2019</year>
<article-title>Structure of a signaling cannabinoid receptor 1-G protein complex</article-title>. <source/>Cell.
<volume>176</volume>: <fpage>448</fpage>–<lpage>458.e12</lpage>.<pub-id pub-id-type="pmid">30639101</pub-id></mixed-citation>
</ref>
<ref id="b63">
<label>63.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shao</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Chapman</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ramesh</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ferrell</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Q.</given-names></name>, and <name name-style="western"><surname>Rosenbaum</surname><given-names>D. M.</given-names></name></person-group>
<year>2019</year>
<article-title>Structure of an allosteric modulator bound to the CB1 cannabinoid receptor</article-title>. <source/>Nat. Chem. Biol.
<volume>15</volume>: <fpage>1199</fpage>–<lpage>1205</lpage>.<pub-id pub-id-type="pmid">31659318</pub-id></mixed-citation>
</ref>
<ref id="b64">
<label>64.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shao</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Yin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chapman</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Grzemska</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, and <name name-style="western"><surname>Rosenbaum</surname><given-names>D. M.</given-names></name></person-group>
<year>2016</year>
<article-title>High-resolution crystal structure of the human CB1 cannabinoid receptor</article-title>. <source/>Nature.
<volume>540</volume>: <fpage>602</fpage>–<lpage>606</lpage>.<pub-id pub-id-type="pmid">27851727</pub-id></mixed-citation>
</ref>
<ref id="b65">
<label>65.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Q.</given-names></name>, and <name name-style="western"><surname>Wu</surname><given-names>B.</given-names></name></person-group>
<year>2019</year>
<article-title>Structural basis for ligand recognition of the human thromboxane A2 receptor</article-title>. <source/>Nat. Chem. Biol.
<volume>15</volume>: <fpage>27</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">30510189</pub-id></mixed-citation>
</ref>
<ref id="b66">
<label>66.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taniguchi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sayama</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Uwamizu</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yamashita</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>H. E.</given-names></name>, <name name-style="western"><surname>Nakada-Nakura</surname><given-names>Y.</given-names></name>, <etal></etal></person-group>
<year>2017</year>
<article-title>Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA6</article-title>. <source/>Nature.
<volume>548</volume>: <fpage>356</fpage>–<lpage>360</lpage>.<pub-id pub-id-type="pmid">28792932</pub-id></mixed-citation>
</ref>
<ref id="b67">
<label>67.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakamura</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name></person-group>
<year>2011</year>
<article-title>Leukotriene receptors</article-title>. <source/>Chem. Rev.
<volume>111</volume>: <fpage>6231</fpage>–<lpage>6298</lpage>.<pub-id pub-id-type="pmid">21526749</pub-id></mixed-citation>
</ref>
<ref id="b68">
<label>68.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yokomizo</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name></person-group>
<year>2018</year>
<article-title>Leukotriene receptors as potential therapeutic targets</article-title>. <source/>J. Clin. Invest.
<volume>128</volume>: <fpage>2691</fpage>–<lpage>2701</lpage>.<pub-id pub-id-type="pmid">29757196</pub-id></mixed-citation>
</ref>
<ref id="b69">
<label>69.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kita</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kohira</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hamano</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Tokuoka</surname><given-names>S. M.</given-names></name>, and <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name></person-group>
<year>2015</year>
<article-title>A comprehensive quantification method for eicosanoids and related compounds by using liquid chromatography/mass spectrometry with high speed continuous ionization polarity switching</article-title>. <source/>J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.
<volume>995–996</volume>: <fpage>74</fpage>–<lpage>84</lpage>.</mixed-citation>
</ref>
<ref id="b70">
<label>70.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kono</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Conlon</surname><given-names>E. G.</given-names></name>, <name name-style="western"><surname>Lux</surname><given-names>S. Y.</given-names></name>, <name name-style="western"><surname>Yanagida</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Hla</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Proia</surname><given-names>R. L.</given-names></name></person-group>
<year>2017</year>
<article-title>Bioluminescence imaging of G protein-coupled receptor activation in living mice</article-title>. <source/>Nat. Commun.
<volume>8</volume>: <fpage>1163</fpage>.<pub-id pub-id-type="pmid">29079828</pub-id></mixed-citation>
</ref>
<ref id="b71">
<label>71.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harayama</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Riezman</surname><given-names>H.</given-names></name></person-group>
<year>2018</year>
<article-title>Understanding the diversity of membrane lipid composition</article-title>. <source/>Nat. Rev. Mol. Cell Biol.
<volume>19</volume>: <fpage>281</fpage>–<lpage>296</lpage>.<pub-id pub-id-type="pmid">29410529</pub-id></mixed-citation>
</ref>
<ref id="b72">
<label>72.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harayama</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Eto</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Shindou</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kita</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Otsubo</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Hishikawa</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Ishii</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sakimura</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Mishina</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name></person-group>
<year>2014</year>
<article-title>Lysophospholipid acyltransferases mediate phosphatidylcholine diversification to achieve the physical properties required in vivo</article-title>. <source/>Cell Metab.
<volume>20</volume>: <fpage>295</fpage>–<lpage>305</lpage>.<pub-id pub-id-type="pmid">24981836</pub-id></mixed-citation>
</ref>
<ref id="b73">
<label>73.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hashidate-Yoshida</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Harayama</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hishikawa</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Morimoto</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hamano</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Tokuoka</surname><given-names>S. M.</given-names></name>, <name name-style="western"><surname>Eto</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tamura-Nakano</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yanobu-Takanashi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Mukumoto</surname><given-names>Y.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport</article-title>. <source/>eLife.
<volume>4</volume>: <fpage>e06328</fpage>.</mixed-citation>
</ref>
<ref id="b74">
<label>74.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iizuka-Hishikawa</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Hishikawa</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sasaki</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Takubo</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Goto</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nagata</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Nakanishi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Shindou</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Okamura</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>C.</given-names></name>, <etal></etal></person-group>
<year>2017</year>
<article-title>Lysophosphatidic acid acyltransferase 3 tunes the membrane status of germ cells by incorporating docosahexaenoic acid during spermatogenesis</article-title>. <source/>J. Biol. Chem.
<volume>292</volume>: <fpage>12065</fpage>–<lpage>12076</lpage>.<pub-id pub-id-type="pmid">28578315</pub-id></mixed-citation>
</ref>
<ref id="b75">
<label>75.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shindou</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Koso</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Sasaki</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Nakanishi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Sagara</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Nakagawa</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Hishikawa</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Iizuka-Hishikawa</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Tokumasu</surname><given-names>F.</given-names></name>, <etal></etal></person-group>
<year>2017</year>
<article-title>Docosahexaenoic acid preserves visual function by maintaining correct disc morphology in retinal photoreceptor cells</article-title>. <source/>J. Biol. Chem.
<volume>292</volume>: <fpage>12054</fpage>–<lpage>12064</lpage>.<pub-id pub-id-type="pmid">28578316</pub-id></mixed-citation>
</ref>
<ref id="b76">
<label>76.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>H-C.</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sasaki</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kubo</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Matsuda</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nakasaki</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Hattori</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Udagawa</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Kono</surname><given-names>N.</given-names></name>, <etal></etal></person-group>
<year>2012</year>
<article-title>LPIAT1 regulates arachidonic acid content in phosphatidylinositol and is required for cortical lamination in mice</article-title>. <source/>Mol. Biol. Cell.
<volume>23</volume>: <fpage>4689</fpage>–<lpage>4700</lpage>.<pub-id pub-id-type="pmid">23097495</pub-id></mixed-citation>
</ref>
<ref id="b77">
<label>77.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>L. N.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Shui</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Cazenave-Gassiot</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wenk</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Goh</surname><given-names>E. L. K.</given-names></name>, and <name name-style="western"><surname>Silver</surname><given-names>D. L.</given-names></name></person-group>
<year>2014</year>
<article-title>Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid</article-title>. <source/>Nature.
<volume>509</volume>: <fpage>503</fpage>–<lpage>506</lpage>.<pub-id pub-id-type="pmid">24828044</pub-id></mixed-citation>
</ref>
<ref id="b78">
<label>78.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thiés</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Delachambre</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>Bentejac</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lagarde</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Lecerf</surname><given-names>J.</given-names></name></person-group>
<year>1992</year>
<article-title>Unsaturated fatty acids esterified in 2-acyl-1-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form</article-title>. <source/>J. Neurochem.
<volume>59</volume>: <fpage>1110</fpage>–<lpage>1116</lpage>.<pub-id pub-id-type="pmid">1494901</pub-id></mixed-citation>
</ref>
<ref id="b79">
<label>79.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yalagala</surname><given-names>P. C. R.</given-names></name>, <name name-style="western"><surname>Sugasini</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Zaldua</surname><given-names>S. B.</given-names></name>, <name name-style="western"><surname>Tai</surname><given-names>L. M.</given-names></name>, and <name name-style="western"><surname>Subbaiah</surname><given-names>P. V.</given-names></name></person-group>
<year>2020</year>
<article-title>Lipase treatment of dietary krill oil, but not fish oil, enables enrichment of brain eicosapentaenoic acid and docosahexaenoic acid</article-title>. <source/>Mol. Nutr. Food Res. In press.</mixed-citation>
</ref>
<ref id="b80">
<label>80.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Bartke</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Van Daele</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lawrence</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Qin</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>H. G.</given-names></name>, <name name-style="western"><surname>Kothapalli</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Windust</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bindels</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>, <etal></etal></person-group>
<year>2014</year>
<article-title>Higher efficacy of dietary DHA provided as a phospholipid than as a triglyceride for brain DHA accretion in neonatal piglets</article-title>. <source/>J. Lipid Res.
<volume>55</volume>: <fpage>531</fpage>–<lpage>539</lpage>.<pub-id pub-id-type="pmid">24470588</pub-id></mixed-citation>
</ref>
<ref id="b81">
<label>81.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>da Costa</surname><given-names>K-A.</given-names></name>, <name name-style="western"><surname>Rai</surname><given-names>K. S.</given-names></name>, <name name-style="western"><surname>Craciunescu</surname><given-names>C. N.</given-names></name>, <name name-style="western"><surname>Parikh</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Mehedint</surname><given-names>M. G.</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>L. M.</given-names></name>, <name name-style="western"><surname>McLean-Pottinger</surname><given-names>A.</given-names></name>, and <name name-style="western"><surname>Zeisel</surname><given-names>S. H.</given-names></name></person-group>
<year>2010</year>
<article-title>Dietary docosahexaenoic acid supplementation modulates hippocampal development in the Pemt-/- mouse</article-title>. <source/>J. Biol. Chem.
<volume>285</volume>: <fpage>1008</fpage>–<lpage>1015</lpage>.<pub-id pub-id-type="pmid">19889625</pub-id></mixed-citation>
</ref>
<ref id="b82">
<label>82.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veglia</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Tyurin</surname><given-names>V. A.</given-names></name>, <name name-style="western"><surname>Blasi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>De Leo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kossenkov</surname><given-names>A. V.</given-names></name>, <name name-style="western"><surname>Donthireddy</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>To</surname><given-names>T. K. J.</given-names></name>, <name name-style="western"><surname>Schug</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Basu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name>, <etal></etal></person-group>
<year>2019</year>
<article-title>Fatty acid transport protein 2 reprograms neutrophils in cancer</article-title>. <source/>Nature.
<volume>569</volume>: <fpage>73</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">30996346</pub-id></mixed-citation>
</ref>
<ref id="b83">
<label>83.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antonny</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Vanni</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Shindou</surname><given-names>H.</given-names></name>, and <name name-style="western"><surname>Ferreira</surname><given-names>T.</given-names></name></person-group>
<year>2015</year>
<article-title>From zero to six double bonds: phospholipid unsaturation and organelle function</article-title>. <source/>Trends Cell Biol.
<volume>25</volume>: <fpage>427</fpage>–<lpage>436</lpage>.<pub-id pub-id-type="pmid">25906908</pub-id></mixed-citation>
</ref>
<ref id="b84">
<label>84.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Santis</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Varela</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sot</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>D’Errico</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Goñi</surname><given-names>F. M.</given-names></name>, and <name name-style="western"><surname>Alonso</surname><given-names>A.</given-names></name></person-group>
<year>2018</year>
<article-title>Omega-3 polyunsaturated fatty acids do not fluidify bilayers in the liquid-crystalline state</article-title>. <source/>Sci. Rep.
<volume>8</volume>: <fpage>16240</fpage>.<pub-id pub-id-type="pmid">30389959</pub-id></mixed-citation>
</ref>
<ref id="b85">
<label>85.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Budin</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>de Rond</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>L. J. G.</given-names></name>, <name name-style="western"><surname>Petzold</surname><given-names>C. J.</given-names></name>, and <name name-style="western"><surname>Keasling</surname><given-names>J. D.</given-names></name></person-group>
<year>2018</year>
<article-title>Viscous control of cellular respiration by membrane lipid composition</article-title>. <source/>Science.
<volume>362</volume>: <fpage>1186</fpage>–<lpage>1189</lpage>.<pub-id pub-id-type="pmid">30361388</pub-id></mixed-citation>
</ref>
<ref id="b86">
<label>86.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballweg</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sezgin</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Doktorova</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Covino</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Reinhard</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wunnicke</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Hänelt</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Levental</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Hummer</surname><given-names>G.</given-names></name>, and <name name-style="western"><surname>Ernst</surname><given-names>R.</given-names></name></person-group>
<year>2020</year>
<article-title>Regulation of lipid saturation without sensing membrane fluidity</article-title>. <source/>Nat. Commun.
<volume>11</volume>: <fpage>756</fpage>.<pub-id pub-id-type="pmid">32029718</pub-id></mixed-citation>
</ref>
<ref id="b87">
<label>87.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vásquez</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Krieg</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lockhead</surname><given-names>D.</given-names></name>, and <name name-style="western"><surname>Goodman</surname><given-names>M. B.</given-names></name></person-group>
<year>2014</year>
<article-title>Phospholipids that contain polyunsaturated fatty acids enhance neuronal cell mechanics and touch sensation</article-title>. <source/>Cell Rep.
<volume>6</volume>: <fpage>70</fpage>–<lpage>80</lpage>.<pub-id pub-id-type="pmid">24388754</pub-id></mixed-citation>
</ref>
<ref id="b88">
<label>88.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hyvönen</surname><given-names>M. T.</given-names></name>, and <name name-style="western"><surname>Kovanen</surname><given-names>P. T.</given-names></name></person-group>
<year>2005</year>
<article-title>Molecular dynamics simulations of unsaturated lipid bilayers: effects of varying the numbers of double bonds</article-title>. <source/>Eur. Biophys. J.
<volume>34</volume>: <fpage>294</fpage>–<lpage>305</lpage>.<pub-id pub-id-type="pmid">15688184</pub-id></mixed-citation>
</ref>
<ref id="b89">
<label>89.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magdeleine</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gautier</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gounon</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Barelli</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Vanni</surname><given-names>S.</given-names></name>, and <name name-style="western"><surname>Antonny</surname><given-names>B.</given-names></name></person-group>
<year>2016</year>
<article-title>A filter at the entrance of the Golgi that selects vesicles according to size and bulk lipid composition</article-title>. <source/>eLife.
<volume>5</volume>: <fpage>e16988</fpage>.<pub-id pub-id-type="pmid">27458799</pub-id></mixed-citation>
</ref>
<ref id="b90">
<label>90.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pinot</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Vanni</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Pagnotta</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lacas-Gervais</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Payet</surname><given-names>L. A.</given-names></name>, <name name-style="western"><surname>Ferreira</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Gautier</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Goud</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Antonny</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Barelli</surname><given-names>H.</given-names></name></person-group>
<year>2014</year>
<article-title>Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins</article-title>. <source/>Science.
<volume>345</volume>: <fpage>693</fpage>–<lpage>697</lpage>.<pub-id pub-id-type="pmid">25104391</pub-id></mixed-citation>
</ref>
<ref id="b91">
<label>91.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tiberti</surname><given-names>M. L.</given-names></name>, <name name-style="western"><surname>Antonny</surname><given-names>B.</given-names></name>, and <name name-style="western"><surname>Gautier</surname><given-names>R.</given-names></name></person-group>
<year>2020</year>
<article-title>The transbilayer distribution of polyunsaturated phospholipids determines their facilitating effect on membrane deformation</article-title>. <source/>Soft Matter.
<volume>16</volume>: <fpage>1722</fpage>–<lpage>1730</lpage>.<pub-id pub-id-type="pmid">31916552</pub-id></mixed-citation>
</ref>
<ref id="b92">
<label>92.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lorent</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Levental</surname><given-names>K. R.</given-names></name>, <name name-style="western"><surname>Ganesan</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Rivera-Longsworth</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Sezgin</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Doktorova</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Lyman</surname><given-names>E.</given-names></name>, and <name name-style="western"><surname>Levental</surname><given-names>I.</given-names></name></person-group>
<year>2020</year>
<article-title>Plasma membranes are asymmetric in lipid unsaturation, packing and protein shape</article-title>. <source/>Nat. Chem. Biol.
<volume>16</volume>: <fpage>644</fpage>–<lpage>652</lpage>. [Erratum. 2020. <italic>Nat. Chem. Biol</italic>. 16: 710.]<pub-id pub-id-type="pmid">32367017</pub-id></mixed-citation>
</ref>
<ref id="b93">
<label>93.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carrillo-Tripp</surname><given-names>M.</given-names></name>, and <name name-style="western"><surname>Feller</surname><given-names>S. E.</given-names></name></person-group>
<year>2005</year>
<article-title>Evidence for a mechanism by which ω-3 polyunsaturated lipids may affect membrane protein function</article-title>. <source/>Biochemistry.
<volume>44</volume>: <fpage>10164</fpage>–<lpage>10169</lpage>.<pub-id pub-id-type="pmid">16042393</pub-id></mixed-citation>
</ref>
<ref id="b94">
<label>94.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stockwell</surname><given-names>B. R.</given-names></name>, <name name-style="western"><surname>Friedmann Angeli</surname><given-names>J. P.</given-names></name>, <name name-style="western"><surname>Bayir</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Bush</surname><given-names>A. I.</given-names></name>, <name name-style="western"><surname>Conrad</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Dixon</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Fulda</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gascón</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hatzios</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Kagan</surname><given-names>V. E.</given-names></name>, <etal></etal></person-group>
<year>2017</year>
<article-title>Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease</article-title>. <source/>Cell.
<volume>171</volume>: <fpage>273</fpage>–<lpage>285</lpage>.<pub-id pub-id-type="pmid">28985560</pub-id></mixed-citation>
</ref>
<ref id="b95">
<label>95.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>K. E.</given-names></name>, <name name-style="western"><surname>Kielkowska</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Durrant</surname><given-names>T. N.</given-names></name>, <name name-style="western"><surname>Juvin</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Stephens</surname><given-names>L. R.</given-names></name>, and <name name-style="western"><surname>Hawkins</surname><given-names>P. T.</given-names></name></person-group>
<year>2013</year>
<article-title>Lysophosphatidylinositol-acyltransferase-1 (LPIAT1) is required to maintain physiological levels of PtdIns and PtdInsP2 in the mouse</article-title>. <source/>PLoS One.
<volume>8</volume>: <fpage>e58425</fpage>.<pub-id pub-id-type="pmid">23472195</pub-id></mixed-citation>
</ref>
<ref id="b96">
<label>96.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Lou</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>X-C.</given-names></name>, and <name name-style="western"><surname>Ding</surname><given-names>T.</given-names></name></person-group>
<year>2018</year>
<article-title>Lysophosphatidylcholine acyltransferase 3 deficiency impairs 3T3L1 cell adipogenesis through activating Wnt/β-catenin pathway</article-title>. <source/>Biochim. Biophys. Acta Mol. Cell Biol. Lipids.
<volume>1863</volume>: <fpage>834</fpage>–<lpage>843</lpage>.<pub-id pub-id-type="pmid">29673706</pub-id></mixed-citation>
</ref>
<ref id="b97">
<label>97.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Huan</surname><given-names>C.</given-names></name>, and <name name-style="western"><surname>Jiang</surname><given-names>X-C.</given-names></name></person-group>
<year>2019</year>
<article-title>Macrophage lysophosphatidylcholine acyltransferase 3 deficiency-mediated inflammation is not sufficient to induce atherosclerosis in a mouse model</article-title>. <source/>Front. Cardiovasc. Med.
<volume>5</volume>: <fpage>192</fpage>.<pub-id pub-id-type="pmid">30705887</pub-id></mixed-citation>
</ref>
<ref id="b98">
<label>98.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>H-C.</given-names></name>, <name name-style="western"><surname>Kubo</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kono</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Kage-Nakadai</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Gengyo-Ando</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Mitani</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>T.</given-names></name>, and <name name-style="western"><surname>Arai</surname><given-names>H.</given-names></name></person-group>
<year>2012</year>
<article-title>Depletion ofmboa-7, an enzyme that incorporates polyunsaturated fatty acids into phosphatidylinositol (PI), impairs PI 3-phosphate signaling in Caenorhabditis elegans</article-title>. <source/>Genes Cells.
<volume>17</volume>: <fpage>748</fpage>–<lpage>757</lpage>.<pub-id pub-id-type="pmid">22862955</pub-id></mixed-citation>
</ref>
<ref id="b99">
<label>99.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ding</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Lou</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bui</surname><given-names>H. H.</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>M-S.</given-names></name>, and <name name-style="western"><surname>Jiang</surname><given-names>X-C.</given-names></name></person-group>
<year>2015</year>
<article-title>Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice</article-title>. <source/>Gastroenterology.
<volume>149</volume>: <fpage>1519</fpage>–<lpage>1529</lpage>.<pub-id pub-id-type="pmid">26226572</pub-id></mixed-citation>
</ref>
<ref id="b100">
<label>100.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rong</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Dunham</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Hedde</surname><given-names>P. N.</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Gratton</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>S. G.</given-names></name>, <name name-style="western"><surname>Ford</surname><given-names>D. A.</given-names></name>, and <name name-style="western"><surname>Tontonoz</surname><given-names>P.</given-names></name></person-group>
<year>2015</year>
<article-title>Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion</article-title>. <source/>eLife.
<volume>4</volume>: <fpage>e06557</fpage>.</mixed-citation>
</ref>
<ref id="b101">
<label>101.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rong</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Palladino</surname><given-names>E. N. D.</given-names></name>, <name name-style="western"><surname>de Aguiar Vallim</surname><given-names>T. Q.</given-names></name>, <name name-style="western"><surname>Ford</surname><given-names>D. A.</given-names></name>, and <name name-style="western"><surname>Tontonoz</surname><given-names>P.</given-names></name></person-group>
<year>2017</year>
<article-title>ER phospholipid composition modulates lipogenesis during feeding and in obesity</article-title>. <source/>J. Clin. Invest.
<volume>127</volume>: <fpage>3640</fpage>–<lpage>3651</lpage>.<pub-id pub-id-type="pmid">28846071</pub-id></mixed-citation>
</ref>
<ref id="b102">
<label>102.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Jalil</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Magnani</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Ishibashi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Queré</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Bourgeois</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Bergas</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Ménégaut</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Patoli</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Le Guern</surname><given-names>N.</given-names></name>, <etal></etal></person-group>
<year>2018</year>
<article-title>LPCAT3 deficiency in hematopoietic cells alters cholesterol and phospholipid homeostasis and promotes atherosclerosis</article-title>. <source/>Atherosclerosis.
<volume>275</volume>: <fpage>409</fpage>–<lpage>418</lpage>.<pub-id pub-id-type="pmid">29866392</pub-id></mixed-citation>
</ref>
<ref id="b103">
<label>103.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Rong</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Palladino</surname><given-names>E. N. D.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Fogelman</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Martín</surname><given-names>M. G.</given-names></name>, <name name-style="western"><surname>Alrefai</surname><given-names>W. A.</given-names></name>, <name name-style="western"><surname>Ford</surname><given-names>D. A.</given-names></name>, and <name name-style="western"><surname>Tontonoz</surname><given-names>P.</given-names></name></person-group>
<year>2018</year>
<article-title>Phospholipid remodeling and cholesterol availability regulate intestinal stemness and tumorigenesis</article-title>. <source/>Cell Stem Cell.
<volume>22</volume>: <fpage>206</fpage>–<lpage>220.e4</lpage>.<pub-id pub-id-type="pmid">29395055</pub-id></mixed-citation>
</ref>
<ref id="b104">
<label>104.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben M’barek</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ajjaji</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Chorlay</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Vanni</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Forêt</surname><given-names>L.</given-names></name>, and <name name-style="western"><surname>Thiam</surname><given-names>A. R.</given-names></name></person-group>
<year>2017</year>
<article-title>ER membrane phospholipids and surface tension control cellular lipid droplet formation</article-title>. <source/>Dev. Cell.
<volume>41</volume>: <fpage>591</fpage>–<lpage>604.e7</lpage>.<pub-id pub-id-type="pmid">28579322</pub-id></mixed-citation>
</ref>
<ref id="b105">
<label>105.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barquissau</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Ghandour</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Ailhaud</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Klingenspor</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Langin</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Amri</surname><given-names>E-Z.</given-names></name>, and <name name-style="western"><surname>Pisani</surname><given-names>D. F.</given-names></name></person-group>
<year>2017</year>
<article-title>Control of adipogenesis by oxylipins, GPCRs and PPARs</article-title>. <source/>Biochimie.
<volume>136</volume>: <fpage>3</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">28034718</pub-id></mixed-citation>
</ref>
<ref id="b106">
<label>106.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johansen</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Rosti</surname><given-names>R. O.</given-names></name>, <name name-style="western"><surname>Musaev</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sticca</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Harripaul</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Zaki</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Çağlayan</surname><given-names>A. O.</given-names></name>, <name name-style="western"><surname>Azam</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sultan</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Froukh</surname><given-names>T.</given-names></name>, <etal></etal></person-group>
<year>2016</year>
<article-title>Mutations in MBOAT7, encoding lysophosphatidylinositol acyltransferase I, lead to intellectual disability accompanied by epilepsy and autistic features</article-title>. <source/>Am. J. Hum. Genet.
<volume>99</volume>: <fpage>912</fpage>–<lpage>916</lpage>.<pub-id pub-id-type="pmid">27616480</pub-id></mixed-citation>
</ref>
<ref id="b107">
<label>107.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>C-X.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>G-Y.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>K-H.</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>H-q.</given-names></name>, and <name name-style="western"><surname>Bao</surname><given-names>M-H.</given-names></name></person-group>
<year>2019</year>
<article-title>Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility</article-title>. <source/>Clin. Res. Hepatol. Gastroenterol.
<volume>43</volume>: <fpage>533</fpage>–<lpage>541</lpage>.<pub-id pub-id-type="pmid">30824369</pub-id></mixed-citation>
</ref>
<ref id="b108">
<label>108.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Helsley</surname><given-names>R. N.</given-names></name>, <name name-style="western"><surname>Varadharajan</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Gromovsky</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Schugar</surname><given-names>R. C.</given-names></name>, <name name-style="western"><surname>Ramachandiran</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Fung</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kabbany</surname><given-names>M. N.</given-names></name>, <name name-style="western"><surname>Banerjee</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Neumann</surname><given-names>C. K.</given-names></name>, <etal></etal></person-group>
<year>2019</year>
<article-title>Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease</article-title>. <source/>eLife.
<volume>8</volume>: <fpage>e49882</fpage>.<pub-id pub-id-type="pmid">31621579</pub-id></mixed-citation>
</ref>
<ref id="b109">
<label>109.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tanaka</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shimanaka</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Caddeo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kubo</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Mao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kubota</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kubota</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Yamauchi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Mancina</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Baselli</surname><given-names>G.</given-names></name>, <etal></etal></person-group>
<year>2020</year>
<article-title>LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover</article-title>. <source/>Gut. In press.</mixed-citation>
</ref>
<ref id="b110">
<label>110.</label>
<mixed-citation publication-type="preprint"><person-group person-group-type="author"><name name-style="western"><surname>Hayashi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yamano</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kono</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Arai</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Fujiwara</surname><given-names>Y.</given-names></name>, and <name name-style="western"><surname>Ichi</surname><given-names>I.</given-names></name></person-group>
<year>2020</year>
<article-title>Phosphorylation of Elovl5 changes its substrate preference to synthesize Mead acid in response to essential fatty acid deficiency</article-title>. <source/>bioRxiv. 10.1101/2020.01.31.929224. </mixed-citation>
</ref>
<ref id="b111">
<label>111.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caires</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sierra-Valdez</surname><given-names>F. J.</given-names></name>, <name name-style="western"><surname>Millet</surname><given-names>J. R. M.</given-names></name>, <name name-style="western"><surname>Herwig</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Roan</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Vásquez</surname><given-names>V.</given-names></name>, and <name name-style="western"><surname>Cordero-Morales</surname><given-names>J. F.</given-names></name></person-group>
<year>2017</year>
<article-title>Omega-3 fatty acids modulate trpv4 function through plasma membrane remodeling</article-title>. <source/>Cell Rep.
<volume>21</volume>: <fpage>246</fpage>–<lpage>258</lpage>.<pub-id pub-id-type="pmid">28978477</pub-id></mixed-citation>
</ref>
<ref id="b112">
<label>112.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niphakis</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Lum</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Cognetta</surname><given-names>A. B.</given-names></name>, <name name-style="western"><surname>Correia</surname><given-names>B. E.</given-names></name>, <name name-style="western"><surname>Ichu</surname><given-names>T-A.</given-names></name>, <name name-style="western"><surname>Olucha</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Kundu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Piscitelli</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Rosen</surname><given-names>H.</given-names></name>, <etal></etal></person-group>
<year>2015</year>
<article-title>A global map of lipid-binding proteins and their ligandability in cells</article-title>. <source/>Cell.
<volume>161</volume>: <fpage>1668</fpage>–<lpage>1680</lpage>.<pub-id pub-id-type="pmid">26091042</pub-id></mixed-citation>
</ref>
<ref id="b113">
<label>113.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doll</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Proneth</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Tyurina</surname><given-names>Y. Y.</given-names></name>, <name name-style="western"><surname>Panzilius</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ingold</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Irmler</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Beckers</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Aichler</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Walch</surname><given-names>A.</given-names></name>, <etal></etal></person-group>
<year>2017</year>
<article-title>ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition</article-title>. <source/>Nat. Chem. Biol.
<volume>13</volume>: <fpage>91</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">27842070</pub-id></mixed-citation>
</ref>
<ref id="b114">
<label>114.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakakuki</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kawano</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Notsu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Imada</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Mizuguchi</surname><given-names>K.</given-names></name>, and <name name-style="western"><surname>Shimano</surname><given-names>H.</given-names></name></person-group>
<year>2014</year>
<article-title>A novel processing system of sterol regulatory element-binding protein-1c regulated by polyunsaturated fatty acid</article-title>. <source/>J. Biochem.
<volume>155</volume>: <fpage>301</fpage>–<lpage>313</lpage>.<pub-id pub-id-type="pmid">24729033</pub-id></mixed-citation>
</ref>
<ref id="b115">
<label>115.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>H. G.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>W. J.</given-names></name>, <name name-style="western"><surname>Kothapalli</surname><given-names>K. S. D.</given-names></name>, and <name name-style="western"><surname>Brenna</surname><given-names>J. T.</given-names></name></person-group>
<year>2015</year>
<article-title>The fatty acid desaturase 2 (FADS2) gene product catalyzes Δ4 desaturation to yield n-3 docosahexaenoic acid and n-6 docosapentaenoic acid in human cells</article-title>. <source/>FASEB J.
<volume>29</volume>: <fpage>3911</fpage>–<lpage>3919</lpage>.<pub-id pub-id-type="pmid">26065859</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>